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The demand for the detection of chemical and biological substances in fields including 
clinical diagnosis, environmental monitoring, forensic analysis and antiterrorism promotes 
the fast growing of powerful analytical technologies. In this regard, water-soluble conjugated 
polymers (CPs) with electron delocalized backbones and highly polar side chains have 
emerged as a versatile building block for the construction of biosensors. Despite the fact that 
various CP based sensors have already been successfully developed, continuous effects are 
still needed to further extend CP applications to those lacking novel sensing methods and to 
develop new CP materials with improved performances. In this thesis, three CP type 
fluorescent/colorimetric sensors based on different mechanisms (Förster resonance energy 
transfer, quenching and conformational change) are developed for the detection of heparin. 
Heparin is a drug commonly used in surgery and long term care to prevent blood coagulation. 
Close monitoring of heparin levels is of great importance to avoid possible serious 
complications induced by heparin overdose. In general, these CP-based sensors have 
common advantageous features such as simple formulation, quick response, high selectivity, 
feasible for visual detection and reasonable quantification ranges, and they may find 
applications in research work requiring quick detection and quantification of purified heparin 
samples or heparin in biological media. Current CP based sensors mostly use conjugated 
polyelectrolytes (CPEs) as sensory materials. Nonspecific interactions between CPEs and 
interfering substances are inevitable and may adversely affect the sensors’ selectivity. In this 
thesis, two functionalized water-soluble nonionic polymers (NCPs) are developed. The 
special monomer units render these NCPs with desirable features including soluble in water, 
optically stable under high ionic strength and minimal nonspecific interactions with 
interfering proteins. In addition, through conjugation between functional groups and biotin 





functionalized NCPs may serve as templates for the development of new NCP probes by 
incorporation of the same monomer units and conjugation with other biorecognition elements. 
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The demand for the accurate detection of chemical species and biologically important 
molecules in fields including clinical diagnosis, environmental monitoring, forensic analysis 
and antiterrorism promotes the fast growing of powerful analytical technologies.
1
 In 
particular, biosensor, an analytical technology stimulated by the development of 
biotechnology, has attracted increasing research and market interest for its advantages such as 
highly sensitive and simple to operate.
2
 A biosensor is an integration of three main parts: a 
receptor, a transducer and a reader device.
3
 The receptor can be a biological material (e.g., 
nucleic acid, enzyme and cell receptor), a biologically derived material or a biomimic 
component, and it interacts (recognizes or binds) with analyte of interest.
3
 The transducer 
then transfers this analyte-receptor interaction into a specific variable (electrochemical, 
optical, mass change) that can be easily measured or quantified by appropriate devices.
3
 The 
research and the development of optical biosensors have experienced an exponential growth 
because this technology has great potential to realize real time, label free detection of 
analytes, which is of great benefit to their practical applications.
4,5
 The development of 
optical biosensors is greatly promoted by the advances in material chemistry and engineering, 
as the performance of optical biosensors is highly relied on the properties of sensory 
materials. In particular, polymeric functional materials such as conjugated polymers (CPs) 
have emerged as a versatile building block for the construction of optical biosensors.
6-21
 
Water-solubility is a prerequisite for CPs in biological applications, conjugated 
polyelectrolytes (CPEs) with water-soluble ionic side chains and nonionic conjugated 





In this chapter, we start with a brief introduction of π-conjugated polymers. In section 1.2 to 
1.4, some current CPE-based sensors are reviewed according to their sensing mechanisms 
(superquenching, Förster resonance energy transfer and conformational change). Despite the 
fact that various CP based sensors have been successfully developed, continuous effects are 
still needed to further extend CP applications especially to those still lacking novel sensing 
methods. In section 1.5, we review heparin and current heparin assays. Heparin is a drug 
commonly used in surgery and long term care to prevent blood coagulation. Close monitoring 
of heparin levels is of great importance to avoid possible serious complications induced by 
heparin overdoes. In this project, we aim at developing CPE-based assays for heparin 
detection and quantification. The specific objectives are listed below:  
 (i) Recently, our group
22
 extended the applications of cationic PFBT type polymers to 
realize visual detection and quantification of heparin, by taking advantage of heparin binding 
induced PFBT aggregation and aggregation enhanced FRET of PFBT. However, the heparin 
quantification range is limited to 0-5.3 U/mL, which is narrower than the heparin clinical 
range (up to 8 U/mL). Therefore, we aim at developing a new CP material with broader 
heparin quantification range. 
(ii) Besides PFBT type heparin sensors, we also aim at developing a new sensory material 
and a new type of sensor with desirable features such as turn on mode and high selectivity. In 
other words, we aim at developing a heparin sensor which shows easily distinguishable 
responses towards heparin and heparin analogues, and is feasible for visual detection. 
(iii) Few of the current heparin sensors have realized real-time naked-eye detection of heparin 
in complex biological media. Therefore, the third objective is to develop a heparin sensor 





In section 1.6, we made a brief summary of CPE-based sensors. We point out that due to the 
intrinsic charge nature, CPE-based sensors have some limitations. We subsequently review 
the recently reported NCPs and their applications. Although highly polar groups were 
introduced, their solubility and quantum yield may still be not satisfying. In addition, only 
few types of NCPs have ever been developed and few have bioapplications. Therefore, 
another main objective of this Ph. D. project is to develop new NCP materials with desirable 
features. 
Through this Ph. D. project, we anticipate (i) developing new CP based 
fluorescent/colorimetric sensors that may have practical applications, (ii) developing new 
functional NCP materials that may serve as templates for the further development of new 
NCP probes. 
1.1 π-Conjugated polymers 
π-Conjugated polymers are macromolecules having backbones with pi delocalized electronic 
structures. The bandgaps of CPs can be desirably fine-tuned using different backbones. 
Scheme 1.1 shows the backbone structures of some representative CPs, including 
polyacetylenes (PAs), poly(arylene vinylene)s (PAVs), poly(para-phenylene)s (PPPs), 
polyfluorenes (PFs), poly(arylene ethynylene)s (PAEs), polyanilines (PANIs), polypyrroles 






Scheme 1.1 Chemical structures of some common CPs. 
Traditional applications of CPs range from early anti-static coating, energy storage, 
electromagnetic interference shielding using doped CPs to later organic optoelectronics using 
pristine CPs.
23
 More recently, CPs have emerged as attractive platforms for the trace 
detection of chemical species or biologically important molecules, benefiting from their 
easily perturbed properties such as conductivity, chemical potential, absorption and 
fluorescence.
20
 Their backbones can be envisioned as large delocalized π conjugated systems 
feasible for rapid intra/inter chain energy/electron transfer. As compared with their small 
molecule counterparts, CPs have the key advantage of capable of exhibiting collective 




Water-solubility is often a prerequisite for most CPs in biological applications. However, the 
rigid CP backbones tend to aggregate through hydrophobic and π-π stacking interactions, 
promoting nonemissive exciton relaxation pathways and leading to significant quenching of 
CP fluorescence.
24
 Water-dispersible CPs are therefore developed mainly through 
modification of side chains by introducing different polar groups.
25-29
 Based on the charge 
sign of functional groups, water-soluble CPs can be categorized into four types: cationic CPs 
(CCPs), anionic CPs (ACPs), zwitterionic CPs (ZCPs), and nonionic CPs (NCPs). The first 
three types (CCPs, ACPs and ZCPs), being characterized as CPs with water-soluble ionic 
side chains, are also named conjugated polyelectrolytes (CPEs, Scheme 1.2).  
The charged CPE side chains and the hydrophobic CPE aromatic backbones enable CPEs to 
interact with other molecules through electrostatic and hydrophobic interactions. During the 
sensing processes, these two interactions drive CPEs and particular molecules into close 





CPE-based optical sensors can be categorized into three types: quencher or CP 
self-aggregation induced CP amplified quenching, Förster resonance energy transfer (FRET) 
from donor CPs to acceptor fluorophores and analyte induced CP conformational change. 








































Scheme 1.2 Chemical structures of some water-soluble CPEs. 
1.2. Sensors based on quenching  
In 1995, Swager and coworkers
30,31
 demonstrated the first example of amplified quenching of 
PPE-cyclophane (Scheme 1.3A) by an electron accepting quencher methyl viologen (MV
2+
, 
Scheme 1.3A). They pointed out that for conventional monomeric sensors, quenching occurs 
in those receptors forming complexes with quenchers. While in the “molecular wire 
approaches”, the facial exciton migration enables exciton to reach multiple receptor sites 
within its life time, and any complexation between the quencher and a single receptor site 
will lead to the quenching of CP fluorescence (Scheme 1.3B). Stern-Volmer relationship is 
used to describe the kinetics of the quenching process.  
   ⁄                               Equation 1.1 
In this equation,    and   are the fluorescence intensities observed in the absence and 
presence of the quencher, respectively;     is the concentration of the quencher, and     is 
the Stern-Volmer constant, which quantifies the quenching efficiency. Compared with the 
monomeric sensor utilizing oligo-cyclophane (Scheme 1.3A), up to 65-fold enhancement in 





. Although Swager and coworkers used neutral, organically soluble CPs, the 







Scheme 1.3 (A) Chemical structures of PPE-cyclophane, oligo-cyclophane and MV
2+
. (B) 




 extended the “molecular wire approach” to aqueous solutions using 
PPV-SO3
-
 (Scheme 1.2) and MV
2+
. Compared with Swager’s PPE-cyclophane/MV2+ system, 




) was achieved. Whitten and 
coworkers attributed this superquenching of PPV-SO3
-





 through electrostatic interactions; amplified 
static quenching of PPV-SO3
- 
 by the quencher MV
2+
 through electron transfer (molecular 




backbone aggregation, which leads to the 












33% reduction in emission








promotion of intermolecular pathways for excitons to reach quencher sites. Whitten and 
coworkers also demonstrated the application of this superquenching phenomenon using a 
“quencher-tether-ligand (QTL)” approach (Scheme 1.4). A methyl viologen linked biotin 
probe (MV-B, Scheme 1.4A) was used to quench the fluorescence of PPV-SO3
-
, and the 
proposed mechanism is that avidin could form complex with biotin and draw MV-B away 
from PPV-SO3
-
, resulting in the fluorescence recovery of the polymer. 
 




In 2004, Bazan and coworkers
33
 reported the detailed study of PPV-SO3
-
/MV-B/avidin 
system, and they pointed out that nonspecific electrostatic and hydrophobic interactions 
between PPV-SO
3-
 and avidin also exit and affect the CP fluorescence. Despite some disputes 
about PPV-SO3
-
/MV-B/avidin system, the concept of QTL approach is important as later 
Heeger and coworkers
34
 pointed out that the ligand can be replaced by other receptors such as 
antigen, deoxyribonucleic acid (DNA), or enzyme substrate for the highly sensitive detection 
of the hosts such as antibody, complementary DNA or enzyme through receptor-host 

















In addition to small molecule quenchers, proteins can also function as quenchers to quench 
CP fluorescence. In 2002, Heeger and coworkers
38
 reported that cytochrome c (Cyt C) can 
quench PPV-SO3
-





Cyt C is a heme protein with an electron deficient heme center; in addition, at neutral pH, Cyt 
C is cationic and can bind with polyanions and adopt a conformation ready for rapid electron 
transfer. Distinguish between Cyt C and control proteins such as myoglobin another heme 
protein but with lower electron transfer ability, or lysozyme a protein containing no electron 
transfer center was realized.  
Bunz and coworkers
39
 further studied the nonspecific interactions between several proteins 
and carboxylate substituted PPE (PPE-gluco-CO2
-
, Scheme 1.2). They pointed out that 
proteins without quenching centers (such as histone and lysozyme) can also induce indirect 
CP fluorescence quenching through induced CP aggregation via nonspecific electrostatic and 
hydrophobic interactions. Later, Bunz, Rotello and coworkers
40
 developed a sensor array 
containing six different PPEs for the multiple protein detection with an accuracy up to 97%.  
CP superquenching is also applied for enzyme detection. Enzyme catalyzed reaction 
processes induce either introduction or removal of the quenchers from the CP systems, or 
induce aggregation or deaggregation of CP backbones, resulting in turn-off or turn-on of CP 
fluorescence.
41-50









 small organic molecules (p-nitroanilide, rhodamine etc.),
46,47
 or metalloprotein (Cyt 
C);
48
 and the deaggregation agents can be lipid
49




In 2004, Schanze and coworkers
46
 reported the amplified fluorescence sensing of protease 
activity using PPEs with sulfonate (PPE-SO3
-
, Scheme 1.2) or carboxylate (PPE-CO2
-
, 





of peptide bonds. Fluorescence turn-on and turn-off approaches were proposed for peptidase 
and papain activity detection, respectively. In the turn-on approach, quencher p-nitroanilide 
(pNA) labeled lysine (K-pNA, Scheme 1.5A) was used as the substrate. Columbic 
interactions brought K-pNA and PPE-SO3
-
 into close proximity and the polymer fluorescence 
was significantly quenched. Introduction of peptidase into the solution led to the catalytic 
cleavage of the peptide bond, and the charge neutral quencher moieties pNA was liberated 
and PPE-SO3
-
 fluorescence was recovered. In the turn-off approach, a bis-arginine derivative 
of the dye Rhodamine-110 (Rho-Arg2, Scheme 1.5A) was used as the substrate. Rho-Arg2 is 
colorless and non-fluorescent, and it cannot quench the fluorescence of PPE-CO2
- 
(Scheme 
1.2). Introduction of papain resulted in the hydrolysis of Rho-Arg2 and the cationic quencher 
Rho-Arg (Scheme 1.5A) was produced. Effective energy transfer between PPE-CO2
-
 and 
Rho-Arg occurred and PPE-CO2
-
 fluorescence was significantly quenched. PPE-CO2
-
 was 
specially chosen because its emission spectrum overlapped well with the absorption spectrum 
of the rhodamine dye, a condition under which the energy transfer was efficient. The 
proposed turn-off assay was very sensitive with a detection limit of 3.5 nM for papain. Signal 
amplification for about 6-10 times was achieved compared with the assay using Rho-Arg2 
alone. The above advantages of the assays suggest their potential applications in fluorescence 






Scheme 1.5 (A) Chemical structures of K-pNA, Rho-Arg2 and Rho-Arg. (B) Schematic 
illustration of PPE based “turn on” and “turn off” assays for protease activity study.46 
Schanze and co-workers
49
 developed a real time, fluorescence turn-off assay for 
phospholipase C (PLC) activity detection, based on the aggregation induced quenching and 
lipid induced dequenching phenomena. Polymer BpPPE-SO3
- 
(Scheme 1.2) was used in this 
assay. BpPPE-SO3
-
 emitted weak fluorescence and its emission appeared as a broad, 
structureless band with a large stoke shift, indicating that the polymer was in the aggregated 
form. 1,2-Didecanoyl-sn-glycero-3-phosphocholine (10CPC, Scheme 1.6A) is a nature 
enzyme substrate. Its zwitterionic end can interact with polymer side chain ionic groups 
through ion-dipole interaction and its tail can interact with polymer backbones through 
hydrophobic interaction. Combination of these two interactions caused the disruption of 
BpPPE-SO3
- 
self aggregation alone with a significant emission intensity increase. 
Introduction of PLC into the 10CPC/BpPPE-SO3
-
 complex induced the catalytic hydrolysis of 
10CPC, and the originally amphiphilic 10CPC broke into two parts: zwitterionic head group 
phosphorylcholine (Scheme 1.6A) with a net negative charge and the neutral hydrophobic tail 
DAG (Scheme 1.6A). Neither of these two products could disrupt polymer-polymer 
(A)













interactions and polymer aggregates were formed alone with the quenching of polymer 
fluorescence.  
 
Scheme 1.6 (A) Scheme for the hydrolysis of substrate 10CPC by PLC into DAG and 
phosphorylcholine. (B) Mechanism of PLC turn off assay.
49
 
1.3 Sensors based on Förster resonance energy transfer 
Förster resonance energy transfer (FRET) is an electrodynamic phenomenon whereby an 
excited state donor transfers energy to an acceptor through long-range dipole-dipole 
interactions.
51
 The energy transfer rate       (   ) is given by, 





   
)                       Equation 1.2 
where,     is center-to-center distance between the donor and the acceptor;    is the donor 
lifetime in the absence of the acceptor;    is Förster critical distance, which can be 
calculated from the following equations, 
    
     (    )   
  ( )
        
   ⁄                     Equation 1.3 
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where, QD is the quantum yield of the donor in the absence of the acceptor;   is orientation 
factor, which describes the relative orientation between the transition dipoles of the donor and 
the acceptor;  ( ) is the overlap integral, which describes the degree of overlap between the 
donor emission   ( )  and the acceptor absorption   ( )  spectrum;   is Avogadro’s 
number; and   is the refraction index of the media. FRET is a distance dependent process, 
which has been widely used in the measurement of distance and the detection of molecular 
interactions in biological systems.
52-55
 
CPs can function as light harvesting antennae to amplify the fluorescence of the acceptors 
through FRET because: (i) CPs have high absorption coefficients and may emit light 
efficiently as their backbones coordinate a large number of absorption units; (ii) CPs’ large, 
electron-delocalized backbone structures allow rapid intra/inter chain energy migration, and 
the photon-generated excitons from the entire chains can ultimately transfer to a small 
number of lower energy sites (molecular wire approach). In addition, CPs’ main chain 
geometries, bandgaps and side chains can be fine-tuned to improve FRET efficiency.  
In 2002, Bazan and coworkers
56
 reported the first CP type FRET based assay for DNA 
sequence identification (Scheme 1.7). The system contains cationic PFP-NMe3
+
 (shown in 
blue, its chemical structure is shown in Scheme 1.2) and chromophore labeled neutral peptide 
nucleic acid (PNA-C*, shown in black). CCP and C* were chosen with optical properties to 
favor FRET. In the presence of single-stranded DNA (ss-DNA, shown in grey), two 
situations may occur. Situation A corresponds to the addition of complementary ss-DNA, 
which hybridizes with PNA-C* to form ss-DNA/PNA-C* complex with multiplex negative 
charges. Electrostatic interaction between ss-DNA/PNA-C* and PFP-NMe3
+ 
brings the two 
into close proximity, and efficient FRET occurs. Situation B corresponds to the addition of  
noncomplementary ss-DNA, which only interacts with PFP-NMe3
+







 remains too large for efficient FRET. Under optimized conditions, 
C* emission was amplified by PFP-NMe3
+ 
~25 times compared with that observed upon 
direct excitation of C*. The high quantum yield of the donor PFP-NMe3
+
 and the good 
spectra overlap between PFP-NMe3
+
 emission and C* absorption contribute to efficient 
FRET. 
 
Scheme 1.7 Schematic representation for the use of cationic water-soluble CP with  specific 





 also replaced PNA-C* with chromophore labeled ss-DNA 
(ss-DNA-C*) for DNA sequence identification. In situation A, complementary ss-DNA 
hybridizes with ss-DNA-C* to form chromophore labeled double-stranded DNA 
(ds-DNA-C*). Strong electrostatic interaction between ds-DNA-C* and PFP-NMe3
+
 brings 
the two into close proximity for efficient FRET. In situation B, the weak electrostatic 
attraction between ss-DNA-C* and PFP-NMe3
+
 and the interference of the 
noncomplementary sequences both lead to less efficient FRET.  
A series of work were done to optimize FRET between CP and ss-DNA-C* or ds-DNA-C* 








parameters in Equations 1.2-1.4 and minimizing CP and C* self-quenching in CP/C* 
complex. 
PCT is an energy wasting pathway, and it is likely to occur and compete with FRET when the 
energy levels of the acceptor are not contained within the orbital energy levels of the donor.
58
 
Polymers with different molecular orbital energy levels were synthesized by substituting 
backbones with either electron donating (methoxy) or withdrawing (fluorine) groups.
58
 
Electron withdrawing substituents enable the energy levels of the chromophores fluorescein 
and Texas Red to be better contained within the energy gap of the CP, and a higher FRET 
efficiency was obtained compared with that in the presence of CP with electron donating 
substituents or unmodified CP.
58
 
FRET conditions can also be optimized. Bazan and coworkers
59
 reported that PFP-NMe3
+
 
with para-substituted phenyl units in the backbone replaced by meta-substituted phenyl units 
yielded meta-type CP with more conformation freedom and improved registry with analyte 
shape. Shortened distance (r) between the donor meta-type CP and the acceptor leads to a 
higher emission intensity compared with that in the presence of para-type CP. A 
water-soluble cationic tetrahedral molecule was also synthesized to optimize the molecular 
orientation (κ) with the acceptor C*.60 Chromophore Cy5 has its absorption maximum at 649 





, Scheme 1.2) with better spectra overlap 
(J(λ)) with Cy5 was synthesized and was used to amplify Cy5 emission in solid surfaces.61 
Interactions within the CP/C* complex also play an importance role in signal amplification.
58
 
Electrostatic interactions are the main driving force to bring the donor CP and the acceptor 
C* into close proximity. The donor and the acceptor form dynamic complex structures. 





self-interactions among CP or C*. Self-interaction among CP can lead to CP aggregation and 
lower its quantum yield (QD) in solution. Self-interaction among C* can also lead to C* 
fluorescence quenching, which also leads to reduced signal amplification.
58
 Polymers with 
lower charge densities were synthesized.
62
 Loose complex was formed between CP and C*, 





 adding appropriate surfactant,
63
 adding co-solvent, 
63
 carrying 
out the assay on the surface of nanoparticles
64
 all lead to the reduced fluorescence quenching, 
and improved signal amplifications were achieved. 
FRET-based DNA sensors were developed using CPs as light-harvesting antennae in 
conjunction with DNA hybridization event. Following the same principle, other FRET-based 
sensors can also be developed by combining CPs with other “receptor-host” recognitions 
such as biotin-streptavidin recognition.
65
 Wang and coworkers
65
 reported an assay for the 
detection of streptavidin using PFP-NMe3
+
 as the energy donor and fluorescein labeled biotin 
(Fl-B) as the acceptor. The assay working mechanism is shown in Scheme 1.8. Addition of 
proteins into Fl-B solution leads to two situations. Situation A corresponds to the addition of 
streptavidin, which specifically associates with the Fl-B biotin moiety along with the 
fluorescein moiety being deeply buried in the adjacent vacant binding site. Although 
interaction between PFP-NMe3
+
 and streptavidin/Fl-B still exists, the distance between CP 
and fluorescein does not meet the requirement for efficient FRET. Situation B corresponds to 
the addition of nonspecific protein BSA, which does not interact with Fl-B. Electrostatic 
interaction between PFP-NMe3
+







Scheme 1.8 Schematic illustration of protein assay operation.
65
 
Besides biomolecules such as DNA and proteins, small molecules such as toxic molecules 
can also be detected. Zhu and coworkers
66
 reported a CP based method to detect hydrogen 
peroxide (H2O2), and they also reported an assay for the indirect detection of glucose by 
coupling this H2O2 probe with an enzymatic oxidase. The H2O2 probe is composed of 
PFP-NMe3
+
 and a boronate-functionalized fluorescein derivative (FI-BB, Scheme 1.9). In the 





 emits strong fluorescence. Addition of H2O2 leads to the liberation of fluorescein 
(Fl, Scheme 1.9), which exists as a monoanion or dianion in the pH range 5.4-9.1. 
Electrostatic interaction between Fl and PFP-NMe3
+
 brings them into close proximity to favor 
FRET, leading to the decrease of PFP-NMe3
+
 emission intensity and enhanced Fl emission. 
H2O2 could be detected down to 15 nM. Many oxidases generate H2O2 when catalyzing the 
oxidation of their substrates. By incorporation of glucose oxidase, an enzyme which 
generates H2O2 when catalyzing the oxidation of glucose substrate (Scheme 1.9), this H2O2 
probe can also serve as a sensor for β-D-(+)-glucose detection. The detection limit for glucose 














Scheme 1.9 Schematic illustration of the glucose sensor operation.
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1.4 Sensors based on conformational change 
Polythiophenes (PTs) can transduce backbone conformational alternations into detectable 
optical signals.
67-75
 Through non-covalent interactions (electrostatic, hydrophobic, hydrogen 
bonding) with oligomers or polymers (such as nucleic acid, peptide, protein and 
saccharide),
67-75
 polythiophenes can adopt different backbone geometries, resulting in the 
alternation of effective conjugation lengths as well as optical outputs.  
In 2002, Leclerc and coworkers
76
 reported the detection of DNA hybridization event using 
PT-imidazolium (Scheme 1.2, 1.10). The presence of 4-methyl group on each thiophene ring 
is essential, because it introduces steric hindrance which allows easy conformational change 
of polythiophene backbone. Meanwhile, side chain in 3 position of each thiophene ring forces 
the flexible backbone to adopt a random coil conformation.
77,78
 In the absence of any analyte, 
the polymer absorption maximum was at 400 nm and the solution color was yellow. Upon 
binding with ss-DNA through electrostatic interactions, the polymer adopted a highly 
conjugated planar conformation along with a tremendous red-shift of the absorption 
maximum (527) and the solution color was red. The emission maximum of PT also 











and increased interchain interactions. However, in the presence of perfectly matched 
complementary ss-DNA, PT tended to twist itself to wrap around the highly charged ds-DNA 
to form a triplex with high affinity and better solubility. Interchain interactions were 
efficiently suppressed and the emission intensity increased. In addition, the shortening of the 
polymer effective conjugation length led to the blue shift of absorption (421 nm) and 
emission maxima, and the solution color returned to yellow. Colorimetric and fluorometric 
detections of nucleic acids were demonstrated, and the detection limits were 2 × 10
-7





Scheme 1.10 Schematic illustration of the formation of PT/ss-DNA duplex and PT/ds-DNA 
triplex forms. DNA, grey line; PT, yellow, red or orange lines. 76  
Thrombin aptamer is a kind of artificial nucleic acid ligand which can be promoted by target 
protein thrombin to form a quadruplex structure. The same group
68
 also developed an assay 
for the label free detection of human α-thrombin based on the different optical responses of 
PT-imidazolium towards thrombin aptamer in its free form and in its quadruplex structure 
(Scheme 1.11). In the presence of thrombin, the aptamer adopted a quadruplex structure, 
which partially hindered the planarization and aggregation of PT-imidazolium and the 
solution color was orange. While in the presence of a nonspecific protein, the aptamer can be 
regarded as a specific ss-DNA, which formed a duplex with PT-imidazolium and the solution 







Scheme 1.11 Schematic illustration of the specific detection of human α-thrombin using 





 found that the length of ss-DNA also affects the conformation of 
PT-NEt3
+ 
(Scheme 1.2). The shortest ss-DNA that can effectively induce the planarization of 
PT-NEt3
+
 is 10-mer. A convenient, label-free and real time assay for the visualization of 
ss-DNA cleavage by single-stranded specific nuclease (S1 Nuclease) was developed (Scheme 
1.12). S1 Nuclease is an enzyme which cleaves ss-DNA into small fragments. The assay was 
based on the simple concept that long ss-DNA strand can induce the conformational and 
aggregation changes of PT-NEt3
+
 upon duplex formation (solution color was pink), while the 
DNA fragments produced through cleavage of ss-DNA by S1 Nuclease cannot induce any 
conformational change of PT-NEt3
+
, and the solution color was yellow. The DNA cleavage 
process was therefore monitored through the PT-NEt3
+
 absorption spectra change or was 




Quadruplex structure of 
thrombin aptamer
Thrombin








Scheme 1.12 Schematic illustration of the assay for S1 Nuclease.
79
 
Charge density of the analyte may also affect the PT conformational change and the mode of 
aggregation. Shinkai and coworkers
80,81
 reported that the biologically important small 
molecule adenosine triphosphate (ATP) can induce the aggregation of PT-NEt3
+
 backbone as 
indicated by the red-shift of absorption maximum (from 400 nm to 538 nm) and the 
appearance of two vibronic peaks. While equimolar amount of other anionic guests with 
lower charge densities such as adenosine monophosphate (AMP), adenosine diphosphate 
(ADP) and uridine triphosphate (UTP) can only lead to smaller absorption maximum shifts 
(425 nm for AMP, 435 nm for ADP and 461 nm for UTP). The solution colors (yellow for 
ADP, orange for ADP and UTP) differed significantly from that in the presence of ATP 
(pink-red). The above properties were subsequently utilized by Bazan and coworkers
67
 to 
develop a simple, continuous and real-time assay for the direct visualization of glucose 
phosphorylation process which includes the conversion of ATP to ADP by the enzyme 
hexokinase (HK). It is noteworthy that the lack of the obvious optical responses of 
PT-imidazolium towards thrombin (Leclec’s system) or PT-NEt3
+
 towards S1-Nuclease 









Inganäs’s group focused on monitoring the conformational changes of biomolecules through 





or PT-zwitterion (Scheme 1.2). PT-zwitterion can interact with positive or negative 
oligomers and polymers under different pH. In addition, it may also form versatile hydrogen 
bonding patterns with different biomolecules. PT-zwitterion was used to detect the 
conformational change of synthetic peptides,
83
 and later calcium-induced conformation 
change of calmodulin (CaM).
73
 The same group also synthesized a zwitterionic, conjugated 
oligoelectrolyte with the structure similar to that of PT-zwitterion for the detection of disease 
related amyloid fibril formation.
82
  
1.5 Heparin and assays for heparin 
Heparin (Hep) is a highly sulfated glycosaminoglycan.84 It has the highest negative density of 
any know naturally occurring biomolecules and plays an important role in physiological 
processes mainly through electrostatic interactions or hydrogen bonding with diverse proteins 
such as antithrombin, fibroblast growth factor, extracellular superoxide dismutase, 
lipoproteins, etc.85-87 Heparin has been widely used clinically as an intravenous/subcutaneous 
anticoagulant in therapies and in surgeries since 1930s.88 The chemical structure of heparin is 
shown in Scheme 1.13. The main unit of heparin is 1→4 linked uronic acid and glucosamine 
















Heparin (Major unit)  
Scheme 1.13 Chemical structure of heparin. 
Heparin is generally isolated through extraction from animal tissues such as bovine lung, 





slaughterhouses, and the raw heparin is subsequently transferred to pharmaceutical 
companies and is further purified under good manufacturing practices (cGMP) to yield 
pharmaceutical grade heparin or USP (United States Pharmacopeial Convention) heparin 
suitable for further clinical applications.
89
 Potential impurities include other 
glycosaminoglycans such as hyaluronic acid, chondroitin sulfate and heparin sulfate. More 
recently, a semi-synthesized additive, oversulfated chondroitin sulfate (OSCS), has also been 
found.
89
 It is required by Food and Drug Administration (FDA) that raw heparin and USP 
heparin needed to be analyzed through 
1
HNMR, capillary electrophoresis, 
strong-anion-exchange-HPLC (SAX-HPLC) or a well-established assay to identify the 
impurities and to ensure the quality of heparin before use.
90,91
  
Heparin binds to the enzyme inhibitor antithrombin through specific pentasaccharide domains, 
causing the conformational change of antithrombin and resulting in the activation of 
antithrombin through an increase in the flexibility of its reactive site loop. The activated 
antithrombin then inactivates thrombin and other proteases involved in blood clotting, most 
notably factor Xa.88 Close monitoring of heparin level is of vital importance because: (1) 
heparin has a short half-life and needs to be given frequently; (2) heparin is one of the most 
commonly reported anticoagulant involved in medication errors;
92
 and (3) heparin overdose 
may lead to complications such as hemorrhage or thrombocytopenia.93-95 Protamine sulfate, a 
highly cationic peptide, is used to neutralize excess amount of heparin and to reverse the 
anticoagulant effect of heparin through binding to it. The therapeutic dosing level of heparin 
is 2-8 U/mL (18-72 µM based on disaccharide in this thesis) during cardiovascular surgery 
and 0.2-1.2 U/mL (1.8-10.8µM) in postoperative and long-term care.  
Methods to quantify heparin level fall into three types.
96
 The first is protamine titration, 
which measures the minimum amount of protamine needed to neutralize the heparin-induced 





easily automated, and has limited quantification range. It is generally used for research 
purpose.
97
 The second method is to measure the functional activity of heparin by monitoring 
the activated partial thromboplastin time (aPTT). In this method, the sample is collected in 
tubes and citrated, phospholipid, a surface activator and calcium are subsequently added, and 
the clotting time is measured and correlated to the heparin level.
98
 This method is indirect and 
is affected by many factors including: pre-analytical variables (composition of the tube, 
sample processing method), analytical variables (reagent and instrument used) and biological 
variables (coagulation factor levels and variables that affect aPTT time), leading to the poor 
correlation between aPTT and heparin levels.
98,99
 The third method measures heparin 
concentration directly. Electrochemical sensors for heparin were developed using 
polymer-membrane-based ion-selective electrode technology. 
100-103
 The membrane electrode 
is composed of quaternary ammonium anion exchanger, plasticizer and polymer membrane 
matrix. The collective electrostatic interactions between heparin and the relatively immobile, 
positively charged quaternary ammonium anions at the surface of polymer membrane induce 
the boundary potential changes and the variation of signals. The time needed for the 
stabilization of signal is up to 5 min for heparin of low concentrations, which may not be 
suitable for the high-throughput screening of a large amount of samples. A wide variety of 





 and heparin-cationic ion interactions
109-113
 were 
transduced into detectable colorimetric and fluorometric signals. Based on the compositions, 
these sensors can be categorized into three types: host receptor/chromophore labeled guest 
type, cationic chromophore type and chromophore labeled polymer or peptide type. 
Anslyn and coworkers
106
 first reported a colorimetric indicator displacement assay for 
heparin sensing. The host was a hexasubstituted benzene containing ammoniums, amino 





violet. Binding of heparin with this tripodal boronic acid/pyrocatechol violet complex led to 
the displacement of pyrocatechol violent with heparin, and the solution color changed from 
grayish purple to yellow due to the change of dye local environment. Another two types of 
host/guest complexes were also developed. The first one
109
 used polycationic calyx[8]arene 
as the host for heparin binding and the dye eosin Y as the guest. The second one
113
 used five 
different cyclodextrins amide and guanidine derivatives as the hosts and three different 
quinolinium fluorophore tethered lithocholic acids as the guest to form a pattern for heparin 
and heparin analogues detections. All three assays were carried out in buffer solutions.  
Different chromophores for direct heparin sensing were also developed. Anslyn and 
coworkers
107
 labeled 1,3,5-triphenylethynylbenzene with three boronic acid for heparin 
detection. Heparin was quantified through monitoring the fluorescence intensity decrease of 
this chromophore, which was undesirable for direct visual detection. In addition, the 
detection procedure was time consuming, as it took 18 min for the fluorescence intensity to 
stabilize. Benzimidazolium dyes with ammonium and amide groups were also developed for 
fluorometric
112
 detection of heparin, and the quantification range for heparin in buffer was 
0-1.2 U/mL. Recently, Zhu’s group111 synthesized a silole (silacyclopentadiene) carrying 
ammonium groups for the detection of heparin through aggregation-induced enhanced 
emission (AIE) mechanism, however, it tends to aggregate in the presence of nonspecific 
proteins to give strong background signals.  
Dyes can also be tethered with cationic polymer or specific peptide. The chloride ion 
sensitive fluorophore 6-methoxyquinolinium was attached to the peptide AG73.
104
 Binding 
between AG73 and heparin led to the release of chloride ion around the quinolinium and its 
fluorescence was recovered. Heparin can only be accurately quantified in buffer in the range 
of 0-0.4 U/mL. In a similar way, peptide protamine was labeled with dye fluorescein, and 







 A flexible copolymer with its side chains containing boronic acids, dye dansyl, 
dodencyl, ammonium groups and amino-alcohol groups were synthesized. Binding between 
polymer and heparin induced the fluoresce quenching of dansyl dye.
108
 Besides adopting a 
fluorescence “turn off” mode, the heparin quantification ranges of dye labeled protamine and 
dansyl-tethered copolymer were small, about 0-0.65 U/mL and 0.075-0.55U/mL, 
respectively. 
The performance of currently developed heparin optical sensors varied. In general, their 
performance can be judged from several aspects: response time, method (colorimetric or 
fluorometric), work mode (turn off or on), range of quantification, and operation media. 
Sensors with desirable features like simple design, short response time, signal turn-on for 
direct visual detection, appropriate quantification range and compatibility with complex 
biological media are highly desired.  
1.6 Water-soluble nonionic conjugated polymers 
In the preceding sections, we reviewed some recently reported CPE-based sensors. Despite 
the successful applications of CPEs, these types of CPs have some intrinsic limitations. CPEs 
with rigid hydrophobic aromatic backbones often show strong aggregation tendency to lead 
to significant quenching of CP emission.
114
 In addition, the quantum yields of CPEs are often 
affected by the ionic strength and the pH of the media.
83,115
 Moreover, charged CPEs 
generally do not allow further functionalization with biorecognition elements, and CPE-based 
assays often rely on nonspecific electrostatic/hydrophobic interactions between CPEs and 
oppositely charged probes or analytes, which affect assay specificity. 
32-34,39 The stability of 
the assay may also vary during the titration process as the overall charge density may not be 
high enough to compensate the water-alleviation and backbone interactions during this 
charge neutralization process.116-118 To overcome the intrinsic limitations of CPEs, 












. Scheme 1.14 shows the chemical structures of 









In 2002, Swager and coworkers28 reported a nonionic PPE (PPE-amide-OH, Scheme 1.14) 
with its backbone surrounded by many amide and hydroxyl groups. Monomers containing 
polar functional groups were synthesized first, and PPE-amide-OH was subsequently 
synthesized through Sonogashira cross-coupling reaction. PPE-amide-OH was readily soluble 
in water without heating while its analogue (not shown) with less amount of polar functional 
groups showed only slight solubility (est. 0.1 mg·mL
-1
) after heating. Optical properties of 
PPE-amide-OH were studied. Small peaks were observed in the high wavelength region of 
both absorption and fluorescence, and these peaks disappeared after heating. The author 
argued that PPE-amide-OH may in the aggregated form. The quantum yields of 
PPE-amide-OH were 0.07 in water and 0.27 in DMF. The origin of the low quantum yield in 
water was unclear, and the author argued that it was probably due to the strong hydrogen 




 then reported an amphiphilic nonionic PPE, PPE-bOEG (Scheme 
1.14). Monomers attached with two branched oligo(ethylene glycol) (OEG) side chains were 
synthesized first. These non-ionic and non-protic side chains were regarded to provide a 
chemically inert scaffold for the polymer backbone. The polymer was soluble in water (0.70 
mg·mL
-1
) and its quantum yield in water was 0.43, which was much higher than that of 










) or change of 
solution pH (4-11) did not induce any noticeable change of polymer optical properties. Due 
to the readily available monomer building block and the wide application of Sonogashira 
polycondensation protocol in the laboratory scale, the monomer was incorporated into 





 reported a mannose functionalized PPE, PPE-mannose (Scheme 1.14) 





introduced to the monomer first, and the PPE-mannose precursor was then synthesized 
through Sonogashira reaction. The removal of acetate groups yielded the final polymer. Con 
A, a sugar binding protein which specifically binds with mannose, interacted with 




); while the control protein BSA only led to a minute PPE-mannose deaggregation with a 
small intensity increase. Later, Bunz and coworkers
121,122
 reported another two mannose 
functionalized PPEs, PPE-L-mannose and PPE-Tri-mannose (Scheme 1.14). Long linkers 
between mannose groups and CP backbone were introduced to PPE-L-mannose aiming at 
improving side chain flexibility, and more complex sugar substituents were introduced to 
PPE-Tri-mannose aiming at improving its binding with Con A. Improved sensitivities were 








 for PPE-L-mannose and 
PPE-Tri-mannose, respectively.  
Very recently, Bazan and coworkers
124
 reported a mono biotin functionalized polyfluorene 
(PF-OEG-B, Scheme 1.14) and demonstrated its applications. The fluorene monomer was 
attached with two octakis(ethylene glycol) chains, and the polymer was synthesized through 
Grignard metathesis polymerization followed by end functionalized with an alkyne group. 
The polymer can be dissolved in aqueous media and its quantum yield in water (0.8) was 
comparable to those of other water-soluble PFs. Biotin was introduced to the chain end 
through click reaction, and the author showed that PF-OEG-B can bind with streptavidin in 
solid surfaces and amplify Alexa Fluor 488 labeled streptavidin ~5 times compared with that 
observed upon direct excitation of the dye. Control experiment using PF-OEG-B precursor 
without biotin functionalization indicated the selectivity of the assay. 
1.7 Summary of CP-based optical sensors 
CP-based optical sensors provide the advantages such as high sensitivity, feasibility for visual 





limit), selectivity, whether suitable for visual detection, and the complexity of the system are 
to be considered. Table 1.1 gives a brief summary of CP-based optical sensors to guide the 
choice of CP-based optical sensors. 















quencher induced CP quenching, FRET between 




and dye labeled 
protein 
FRET between CP and dye 
CP-ligand conjugate 
CP aggregation induced quenching 
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CPE, eg. PT 









FRET between CP and fluorophore, quencher 








substrate or product can remove metal ion from 





CPE and substrate 
CP aggregate in the presence substrate and 
deaggregate in the presence of product, or the 
opposite, CP aggregation induced quenching 
electrostatic interaction 
oppositely charged 
CPE (eg. PT, PFBT) 
and substrate,  






quencher induced CP quenching, FRET between 













quencher induced CP quenching 
CPE, dye labeled 
PNA/DAN 





PT, DNA CP conformational change 
DNA hybridization 
CP-DNA conjugate, 
dye labeled DNA  
FRET between CP and dye 
DNA visual 
quantification 
electrostatic interaction PFBT, DNA 
CP aggregation induced FRET/fluorescence 
enhancement 
Table 1.1 A brief summary of CP-based optical sensors. 
 
1.8 Thesis Outline 
This thesis consists of six parts. Chapter 1 describes the research objectives of this project 
followed by literature reviews. In Chapter 2, a new PFBT with high water solubility and low 
inherent BT emission is designed and synthesized. Quantification of heparin by this new 
PFBT in the whole clinical range is demonstrated. In Chapter 3, we present an 
oligoelectrolyte/graphene oxide integrated assay for the light up visual detection of heparin, 
which shows good selectivity towards heparin and heparin analogues. In Chapter 4, a 
polythiophene based assay for the real time naked eye detection of heparin in biological 
media is present. The overall performance of this sensor is compared with those of current 
optical heparin sensors and its advantages are highlighted. In Chapter 5, two new nonionic 
conjugated polymers are designed and synthesized. Compared with CPEs, these NCPs have 
advantages like optically stable under high ionic strength and show minimal nonspecific 
interactions with interfering proteins. After conjugation with ligand, these functionalized 
NCPs also show biorecognition capabilities. Chapter 6 gives the conclusion and 








CATIONIC CONJUGATED POLYMER/HEPARIN 




Heparin (Hep) is a highly sulfated linear acidic polysaccharide.
84
 It plays an important role in 
physiological processes through electrostatic interaction with diverse proteins such as 
antithrombin, fibroblast growth factor, extracellular superoxide dismutase, lipoprotein, 
etc.
85-87
 Heparin has long been used as an anticoagulant to convert antithrombin into suicide 
substrate for procoagulant proteinase.
88
 During the anticoagulant therapy and surgery, close 
monitoring of heparin levels is of vital importance to avoid complications such as 
hemorrhage or thrombocytopenia induced by heparin overdose.
93-95
 The development of 
quick and reliable methods that allow heparin detection and quantification is of practical 
importance.  
Many assays for heparin quantification and/or detection have been established. Traditional 
laboratory assays for heparin quantification are indirect, which rely on monitoring of the 
activated coagulation time (ACT) or the activated partial thromboplastin time (aPTT).
125
 In 
addition, polymer membrane-based potentiometric sensor and electrochemical assays have 
also been used for heparin detection and quantification.
100-103
 These assays are not 
sufficiently accurate and reliable because of their lack of specificity and potential interference 
from other factors.
126
 Recently, fluorescent assays have been reported using synthetic cationic 
chromophores such as benzimidazolium dyes or chromophore-tethered peptides or 
copolymers as the heparin receptors.
104,105,108,112
 In addition, an artificial enzyme-based sensor 
was also reported for heparin detection in nanomolar range.
127
 These fluorescent assays share 





simple heparin quantification methods that could cover the whole therapeutic dosing level are 
highly desirable.  
Conjugated polymers (CPs) are electron-delocalized macromolecules with light-harvesting 
properties for optoelectronic sensors. In particular, cationic CPs (CCPs) provide a unique 
platform for chemical and biological detection due to their sufficient water-solubility and 
strong electrostatic interactions with charged molecules. In 2004, Bazan and coworkers
128
 
reported a cationic polyfluorene derivative containing a fractional substitution of fluorene 
fragments with 2,1,3-benzothiadiazole (BT) units for multi-color DNA sensing. More 
recently, our group extended the biological application of BT-based CCPs to visual heparin 
detection and quantification.
22
 The working hypothesis is that inter-chain FRET is more 
efficient than intra-chain FRET due to stronger electronic coupling and increased transfer 
dimensionality for inter-chain versus intra-chain interactions.
129
 Aggregation induced by 
complexation between the polymer and oppositely charged heparin favors inter-chain FRET 
from the fluorene-phenylene fragments (donor) to the BT units (acceptor), giving rise to a 
blue-to-orange fluorescence change. Although heparin quantification was conducted using 
BT-based CCP, the calibration curve was limited in the range of 0.03 to 48 µM, which 
originated from the relatively strong BT emission at elevated polymer concentrations. Since 
the therapeutic dosing level of heparin for clinical treatment is in the range of 0 to 72 µM, it 
is highly desirable to develop a new polymer with broadened heparin quantification range.  
In this chapter, we demonstrate the design and synthesis of a new water-soluble 
BT-containing PF derivative for heparin quantification. Different from the reported 
BT-containing CCPs, the polymer is fully substituted with cationic oligo(ethylene oxide) side 
chains and the BT content is as high as 20 mol-%. The unique polymer structure ensures 
good water-solubility of the polymer and low BT background signal for heparin 





The polysaccharides selected are heparin, chondroitin 4-sulfate (ChS) and hyaluronic acid 
(HA), the latter two are often found as contaminates for clinical heparin. The main unit of 
heparin is 1→4 linked uronic acid and glucosamine repeating disaccharide unit 
(iduronic-acid-2-sulfate→glucosamine-2, 6-disulfate). On average, Hep carries three sulfate 
groups and one carboxylate group per disaccharide unit. ChS consists of the disaccharide unit 
formed by 1→3 linked N-acetylgalactosamine and glucuronic acid, modified by sulfation in 
the position 4. ChS possesses one sulfate and one carboxylate moiety per disaccharide unit. 
HA is formed by 1→3 linked glucuronic acid and N-acetyglucosamine, which has only one 










































































Scheme 2.1 Chemical structures of Hep, ChS and HA. 
2.2 Experimental part 
2.2.1 Materials 
All chemicals were purchased from Sigma-Aldrich unless otherwise noted. 
2,7-Dibromo-9,9’-bis(2-(2-(2-bromoethoxy)ethoxy)ethyl)fluorene (1), 
2-(9,9-bis(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-7-(4,4,5,5-tertramethyl-1,3,2-dioxaborolan-2





4,7-dibromo-2,1,3-benzothiadiazole (3) were synthesized according to literature reports.
62,130
 
Heparin sodium salt from bovine intestinal mucosa (Fluka) has 170 U/mg. The molecular 
weight of heparin was determined by disaccharide (644.2 g/mol), and 1 µM heparin 
corresponded to 0.11 U/mL. Chondroitin 4-sulfate sodium salt from bovine trachea 
(BioChemika) and hyaluronic acid salt from Streptococcus equi (BioChemika) were used as 
received. Stock solutions of heparin, chondroitin 4-sulfate, and hyaluronic acid in water were 






C nuclear magnetic resonance (NMR) spectra were recorded on a Bruker AMX- 500 
spectrometer using CDCl3 or d4-MeOH as solvent and tetramethylsilane as internal standard. 
Gel permeation chromatography (GPC) analysis was conducted with a Waters 2690 liquid 
chromatography system equipped with a Waters 996 photodiode detector and a Waters 2420 
evaporative light-scattering detector using three Phenogel GPC columns in one loop. 
Monodisperse polystyrenes samples were used for calibration and tetrahydrofuran (THF) was 
used as the mobile phase as a flow rate of 1.0 mL·min
-1
 at 35°C. Absorption spectra were 
recorded on a Shimadzu UV-1700 spectrometer. The software was UV Probe Version 2.21 
and scan speed was “fast”. Fluorescence measurements were carried out on a Perkin-Elmer 
LS-55 instrument equipped with a xenon lamp excitation source and a Hamamatsu (Japan) 
928 photomultiplier tube (PMT), using 90 ° angle detection for solution samples. The 
excitation energy at different wavelength was automatically adjusted to the same level by an 
excitation correction file. The instrument was controlled by FL WinLab Software.  
2.2.3 Synthesis 





Monomers 1 (214.2 mg, 0.3 mmol), 2 (404.1 mg, 0.5 mmol), 3 (58.8 mg, 0.2 mmol), 
tetrakis(triphenylphosphine) palladium Pd(PPh3)4 (9.30 mg, 7.8 mmol), and potassium 
carbonate K2CO3 (829.3 mg, 6.0 mmol) were mixed in a 25 mL round-bottomed flask. A 
mixture of water (3 mL) and toluene (9 mL) was added to the flask, and the reaction vessel 
was degassed. The mixture was vigorously stirred at 90 °C for 24 h under nitrogen and was 
then precipitated into hexane. The polymer was filtered and washed with hexane and acetone 
and was then dried under vacuum for 24 h to afford the polymer 4 as a yellow solid (406.8 
mg, 86.5%). 
1
H NMR (500 MHz, CDCl3), δ (ppm): 7.50−8.14 (m, 5.2H), 3.67 (s, 3.2H), 
3.33−3.45 (m, 9.6H), 2.48-2.96 (m, 6.4H). 13CNMR (125 MHz, CDCl3), δ (ppm): 154.3, 
151.6, 150.2, 149.6, 140.9, 140.8, 140.5, 140.3, 139.2, 136.7, 133.4, 130.6, 128.9, 128.1, 
127.0, 124.2, 121.4, 120.4, 71.1, 70.2, 67.5, 67.3, 67.2, 51.7, 39.8, 30.2. 
2.2.3.2 Synthesis of cationic polymer (PFBT-20%) 
Condensed trimethylamine (TMA, 2 mL) was added drop-wise to a solution of 4 (50.0 mg) in 
THF (10 mL) at -78 °C. The mixture was allowed to warm to room temperature and stirred 
for 24 h. The formed precipitate was dissolved by addition of methanol (10 mL). After the 
mixture was cooled to -78 °C, additional TMA (2 mL) was added. The mixture was stirred at 
room temperature for 24 h. After solvent removal, acetone was added to precipitate PFBT-20% 
at an orange powder (45.8 mg, 76.2%). 
1
HNMR (500 MHz, CD3OD), δ (ppm): 7.78−8.37 (m, 
5.2H), 3.79 (s, 3.2H), 3.28−3.54 (m, 12.8H), 3.13−3.17 (m, 14.4H), 2.64−2.86 (m, 3.2H). 
2.3 Results and discussion 
2.3.1 Synthesis and characterization  
The water-soluble polymer (PFBT-20%) was synthesized through post-polymerization. The 
neutral polymer (4) was obtained by palladium-mediated Suzuki crossing-coupling 










molecular weight and polydispersity of 4 are 6500 and 2.6, respectively, determined by GPC 
using monodisperse polystyrenes as standard and THF as eluent. Quaternization of the 
pendant bromide group in the alkoxy side-chain of 4, by addition of condensed 
trimethylamine at -78 °C, provided the target polymer PFBT-20% in a yield of 76.2% after 
precipitation from acetone and subsequent drying. The degree of quaternization is ≈98% for 
polymer PFBT-20% according to the 
1
H NMR. PFBT-20% has a water solubility of 20 
mg·mL
-1
 measured at 24 ± 1 °C. The good water-solubility of PFBT-20% results from the 
high charge density and the oligo(ethylene oxide) side chains, which is beneficial for 











































4 PFBT-20%  
Scheme 2.2 Synthetic route towards PFBT-20%. Regents and conditions: a) Pd(PPh3)4, 
K2CO3, water/toluene, N2, 90 °C, 24 h; b) TMA, THF/MeOH, room temperature, 48 h. 
The normalized ultraviolet-visible (UV-Vis) absorption and photoluminescence (PL) spectra 
of PFBT-20% in aqueous solution are shown in Figure 2.1. The polymer concentration based 
on repeat unit ([RU]) is 10 µM (one repeat unit has a molecular weight of 564.87 g·mol
-1
, 
which includes 0.8 mol of 9,9-bis[(trimethylammonium)ethoxy]ethoxy)ethyl] fluorene, 0.2 
mol of 2,1,3-benzothiadiazole). The absorption spectrum shows a maximum at 369 nm and a 





segments and the BT units, respectively.
128, 129
 The PL spectrum of PFBT-20% in water upon 
excitation at 365 nm has a maximum at 412 nm with a broad tail from 520 to 640 nm. 
Noteworthy is that even at [RU] = 1.0 × 10
-4
 M, there is no significant BT emission, which is 
ascribed to the good water-solubility of PFBT-20%. 
















































Figure 2.1 Normalized UV-Vis absorption and PL spectra of PFBT-20% in water. [RU] = 10 
µM, λex = 365 nm. 
2.3.2 Effect of ionic strength and polymer concentration on PFBT-20% fluorescence 
The disturbance of ionic strength and polymer concentration on the PL spectra of PFBT-20% 
is studied to highlight the environmental-resistant fluorescence of the polymer. The changes 
in the fluorene (412 nm) and BT (585 nm) emission intensities as a function of ionic strength 
and polymer concentration are monitored and the PL intensity ratio (I585/I412) is summarized 
in Figure 2.2. In dilute polymer solutions ([RU] = 1.0 µM or 10 µM), the ratio changes 
slightly with the increased ionic strength in solution. In contrast, at [RU] = 100
 
µM, 
increasing the ion strength from 0 to 50 mM significantly increases the orange/blue emission 
ratio. Since the detection sensitivity and quantification range are dependent on both the 




























Figure 2.2 The ratio of PL intensity at 585 nm to that at 412 nm for PFBT-20% solutions at 
[RU] = 1.0 µM, 10 µM and 100 µM as a function of PBS concentration, λex=365 nm. 
2.3.3 Heparin titration  
Titration of PFBT-20% ([RU] = 10 µM) with heparin was conducted in 2 mM PBS buffer. In 
these experiments, the heparin was added dropwise at 1 µM interval. As shown in Figure 
2.3A, with the addition of heparin, there is a decrease in intensity for the blue emission band. 
Meanwhile, the BT emission intensity increases gradually and saturates at [Hep] = 4 µM. The 
transformation in the PL spectra reflects gradually increased FRET from the fluorene 
segments (energy donor) to the BT units (energy acceptor) upon PFBT-20%/Hep 
complexation. According to Scheme 2.2, each PFBT-20% RU has 1.6 positive charges. At 
[RU] = 10 µM, the concentration of positive charges in solution is 16 µM. On the other hand, 
since each heparin dimmer has four negative charges, at saturation, the concentration of 
negative charges from heparin is also 16 µM. The nearly identical concentration of opposite 
charges at saturation is consistent with the previous reports that charge balance is essential for 








To understand the origin of increased BT emission intensity upon polymer/heparin 
complexation, the emission spectra of the complex upon direct excitation of BT units at 440 
nm are also monitored (Figure 2.3B). There is an increase in BT emission intensity with the 
addition of heparin and the BT emission also saturates at [Hep] = 4 µM. This observation 
agrees with literature report that the BT containing polymer is environmentally sensitive, and 
the more hydrophobic microenvironment within the complexes favors higher BT emission 
due to the reduced contact between the electronic backbones of the polymer and water 
molecules.
22
 Similar observation is also reported for complexation between a BT containing 
polymer with DNA, where both inter/intra molecular energy transfer and the increase in 
intrinsic BT emission contribute to the overall signal output.
131
 

































































Figure 2.3 Changes in the PL spectra of PFBT-20% upon addition of different amount of 
heparin at different excitation wavelength of (A) 365 nm and (B) 440 nm. The heparin 
concentration changes at intervals of 1 µM upon each addition. Experiments were conducted 
in 2 mM PBS at pH = 7.4, [RU] = 10 µM. 
2.3.4 Polysaccharide titration  
To probe the effect of electrostatic interaction on the optical properties of heparin/polymer 
complexes, heparin derivatives, such as ChS and HA have also been added to PFBT-20% 
solution. Under the same experimental conditions used for Figure 2.3A, addition of 4 µM 
ChS or HA into the PFBT-20% solution did not lead to significant fluorescence decrease in 
the blue emission band, and the BT emission intensity was also much lower than that for 
heparin/PFBT-20% (Figure 2.4). The good selectivity for heparin is associated with much 
stronger electrostatic interactions between heparin and PFBT-20%, as compared to that for 
ChS/PFBT-20% or HA/PFBT-20%, which consequently induces more compact polymer 
aggregation in the presence of heparin to give enhanced BT emission.
62
 





























Figure 2.4. Changes in the PL spectra of PFBT-20% upon addition of different analytes. 
Experiments were conducted in 2 mM PBS at pH = 7.4. [RU] = 10 µM. [Hep] = [ChS] = [HA] 
= 4 µM, λex = 365 nm. 





To demonstrate heparin quantification with PFBT-20%, heparin titration experiments were 
conducted at [RU] = 240 µM in 2 mM PBS (pH = 7.4). Figure 2.5 shows the changes in the 
PL spectra of PFBT-20% upon addition of heparin ranging from 0 to 76 µM. The BT 
emission starts to increase in the presence of 0.2 µM heparin. Upon further addition of 
heparin, the emission band at 585 nm continues to increase, along with the intensity decrease 
at 412 nm. When heparin concentration reaches 76 µM, the BT emission intensity does not 
increase any more, indicating the analyte-receptor saturation. At the saturation point, the 
positive charges (384 µM) from PFBT-20% are ≈20% more than that for the negative charges 
from heparin (304 µM). This is mainly due to the polymer aggregation at high concentration 
(Figure 2.2), which blocks efficient charge paring as compared to that at low polymer 
concentration. 



































Figure 2.5 Changes in the PL spectra of PFBT-20% upon addition of different amounts of 
heparin. The heparin concentration changes from 0 to 4 µM as shown in legend and from 4 to 
76 µM at intervals of 4 µM upon each addition. Experiments were conducted in 2 mM PBS at 
pH = 7.4, [RU] = 240 µM, λex = 365 nm. 
To demonstrate heparin quantification, changes in the PL spectra of PFBT-20% in Figure 2.5 





   (    )                                      
Equation 2.1 
where I and I0 are the intensities at 585 nm in the presence and absence of heparin, 
respectively. The calibration parameter φ is defined to minimize the influence of fluorescence 
background and to estimate the assay sensitivity. Figure 2.6 shows   as a function of 
[heparin] along with its linear trend line. The linearity in the concentration range of 0 to 76 
µM indicates that it is feasible to use PFBT-20% as a heparin probe for heparin quantification. 
Since the heparin concentration at the therapeutic dosing level is 0.2-1.2 U·mL
-1
 (1.8-10.8 
µM) in post-operative and long-term care, and 2-8 U·mL
-1
 (18-72 µM) during cardiovascular 
surgery,
107
 the obtained heparin calibration curve with [RU] = 240 µM can be used for 
full-range detecting of heparin required for clinical applications. At [RU] = 240 µM, the 




 and the correlation coefficient is 0.9998. 
























Figure 2.6 φ as a function of [Heparin] at [RU] = 240 µM in 2 mM PBS at pH = 7.4. The 
data are based on the average value of the two independent experiments at λex = 365 nm. 
2.4 Conclusion 
In summary, we have developed an efficient approach to quantify heparin in the 





fluorescence change of a dual emission polymer upon polymer/heparin complexation. The 
good water-solubility of the polymer leads to low intrinsic polymer aggregation in water and 
low fluorescence of the BT emission prior to analyte addition. This study thus highlights the 
importance of polymer structure design in CPE-based biosensor applications. However, it is 
important to note that the polymer aggregation based strategy is not suitable for heparin 
quantification in complicated biological media, as the high concentration of proteins and 
other biomolecules presence in solution can cause significant background signals. Direct 









A CONJUGATED OLIGOELECTROLYTE/GRAPHENE OXIDE 
INTEGRATED ASSAY FOR LIGHT-UP VISUAL DETECTION OF 
HEPARIN 
 
3.1 Introduction  
In Chapter 2, we modified the PFBT type polymer through attaching oligo(ethyl glycol) 
chains and changing the backbone composition ratio, and realized the quantification of 
heparin in the whole clinical range. In this chapter, we aim at widening the available sensory 
materials and developing a new type of sensor with desirable features like highly selective 
and feasible for heparin visual detection.  
Graphene oxide (GO) is a water-soluble single carbon layer produced by chemical or thermal 
exfoliation of graphene.
132,133
 It possesses epoxy or hydroxyl groups in its basal planes
134
 and 
carboxyl groups in its peripheries
135
 with ordered small graphite domains nonuniformly 
residing in the basal planes.
136
 Abundant oxygen-containing functional groups and aromatic 
domains enable GO to interact with varieties of biomolecules through covalent, non-covalent 
or electrostatic interactions,
132,133,137
 making GO an attractive nanoplatform for 
biosensing.
138-145
 Several GO-based sensors have been developed by taking advantage of 




 on GO surface and subsequent 
efficient fluorescence quenching of the dyes. In these assays, π-π stacking interaction 
between hexagonal cells of GO and ring structures in nucleobases
139
 in conjunction with the 
hydrophobic and electrostatic interactions play important roles in bringing GO and the 
dye-labeled probe into close proximity to quench the dye fluorescence via resonance energy 
or nonradiative dipole-dipole couplings.
138,146-148
 So far, the GO sensors have been 















 These sensors are strongly relied on commercially available dye-labeled DNA, 
peptide or protein as the probe, and as a consequence, their detecting targets are constrained 
due to the limited biorecognition capability of these probes. It is highly desirable to develop 
more general schemes to expand the target for GO based sensing.  
Direct π-π stacking and electrostatic interactions between GO and fluorescent chromophores 
provides an excellent opportunity for the development of label-free sensors, which however 
has been rarely reported to date.
149
 A primary challenge lies in the screening of suitable 
fluorescent chromophores, which show obviously different responses to GO in the presence 
and in the absence of analyte. Pyrene is a polycyclic aromatic hydrocarbon with four fused 
aromatic rings in a flat plane, which mimics the structure of graphitic materials to allow for 
strong π-π stacking with graphite150,151 and carbon nanotube.152-154 A more recent study has 
revealed that pyrene derivatives also have similar strong interactions with GO, and their 
fluorescence can be significantly quenched by GO.
149
 According, it is anticipated that pyrene 
could be an effective building block to develop fluorescent systems for construction of 
label-free GO sensors. 
In this chapter, we demonstrate the design and synthesis of a water-soluble pyrene based 
butterfly-shaped conjugated oligoelectrolyte (TFP) and its integration with GO for heparin 





 and a chromophore-tethered flexible 
copolymers,
108
 which showed fluorescence quenching upon binding with heparin (turn-off 
mode); we show here a heparin sensor based on signal “turn on” mode, which is desirable for 
visual detections. ChS and HA, the two Hep analogues are selected as the non-targets in this 
study (Scheme 2.1). As shown Scheme 3.1, TFP has a highly symmetric structure, which is 
consisted of a central 1,3,6,8-tetrasubstituted pyrene core linked to four cationic fluorene 





π-electron delocalized coplanar structure to favor π-π stacking with GO, but also ensures 
sufficient water-solubility and electrostatic interactions with analytes in aqueous media. 
3.2 Experimental part 
3.2.1 Materials 
All chemicals were purchased form Sigma-Aldrich Chemical Company unless otherwise 
noted. GO was synthesized from graphite by a modified Hummers method.
155
 
1,3,6,8-tetrabromopyrene was synthesized according to the literature.
156
 Stock solutions of 
GO (0.39 mg/mL) in water and TFP (0.2 mM) in water were also prepared. Hep, ChS, HA, 
PBS buffer and Milli-Q water used are the same as those in Chapter 2.  
3.2.2 Instruments 
The NMR spectra were collected on a Bruker ACF 300 (300 MHz) spectrometer or a Bruker 
Avance DRX-500 (500 MHz) spectrometer. The mass spectra were obtained using a 
Finnigan/MAT 95XL-T spectrometer. UV-Vis spectrometer and fluorometer are the same as 
those in Chapter 2. Fluorescence quantum yields (ΦF) were measured using quinine sulfate 
(ΦF = 0.55, in 0.1 M H2SO4) as standard. Photographs of the polymer solutions were taken 
using a Canon EOS 400D digital camera. 
3.2.3 Synthesis 
3.2.3.1 Synthesis of 2-bromo-9,9’-bis(6-bromohexyl)fluorene (2)157 
2-Bromofluorene (5.00 g, 20.4 mmol) was added to a mixture of aqueous potassium 
hydroxide (100 mL, 50 wt%), tetrabutylammonium bromide (0.33 g, 1 mmol), and 
1,6-dibromohexane (28.5 mL, 185 mmol) at 75 °C. After 15 min, the mixture was cooled to 
room temperature and was extracted by dichloromethane three times, the organic layers were 





finally dried over anhydrous MgSO4. After solvent removal, the residue was distilled under 
reduced pressure to remove excess 1,6-dibromohexne. The crude product was purified by 
silica gel column chromatography using hexane and dichloromethane (12 : 1) as the eluent to 
afford a pale yellow viscous oil (8.01 g, 70%). 
1
HNMR (500 MHz, CDCl3) δ (ppm) : 
7.65-7.68 (m, 1H), 7.54-7.57 (m, 1H), 7.44-7.46 (m, 2H), 7.32 (br, 3H), 3.27 (t, 4H, J = 6.8 
Hz), 1.91-1.98 (m, 4H), 1.61-1.70 (m, 4H), 1.04-1.24 (m, 8H), 0.59-0.61 (m, 4H); 
13
CNMR 
(125 MHz, CDCl3) δ(ppm): 152.5, 149.9, 140.1, 140.0, 130.0, 127.6, 127.1, 126.0, 122.8, 
121.1,118.8, 55.2, 40.1, 33.8, 32.6, 29.0, 27.7, 23.4; EI-Mass (m/z): 570.1(M+). 
3.2.3.2 Synthesis of 9,9’-bis(6-bromohexyl)-2-ethynylfluorene (4) 
2 (2.54 g, 4.44 mmol), bis(triphenylphosphine)palladium(II) dichloride (Pd(PPh3)2Cl2) (0.12 
g, 0.17 mmol), copper (I) iodide (CuI) (0.033 g, 0.17 mmol) and triethylamine (30 mL) were 
mixed and bubbled with nitrogen for 10 min. After addition of trimethylsilylacetylene (0.94 
mL, 6.6 mmol), the mixture was stirred and heated up to 70 °C under nitrogen for 12 h. After 
it was cooled to room temperature, the mixture was extracted with dichloromethane several 
times. The separated organic layers were combined and washed with water and brine and 
dried over anhydrous MgSO4. After solvent removal, the crude oil was purified by silica-gel 
column chromatography using hexane as the eluent to afford 
2-(9,9-bis(6-bromohexyl)fluoren-7-yl)ethynyltrimethylsilane (3) as a brown oil (1.45 g, 56%). 
The oil was then treated with a mixture of KOH (1.70 g, 30.3 mmol), THF (30 mL), methanol 
(10 mL) and water (5 mL) for 2 h at room temperature. The mixture was then extracted with 
dichloromethane several times, and the separated organic layers were combined and washed 
with water and dried over anhydrous MgSO4. After solvent removal, the residue was purified 
by silica-gel column chromatography using hexane as the eluent to afford 4 as a yellow liquid 
(1.20 g, 54%). 
1
H NMR (500 MHz, CDCl3) δ (ppm): 7.63−7.69 (m, 2H), 7.46−7.50 (m, 2H), 





4H), 1.06−1.18 (m, 8H), 0.59 (br, 4H); 13C NMR (125 MHz, CDCl3) δ (ppm): 150.6, 150.3, 
141.9, 140.2, 131.2, 127.7, 127.0, 126.4, 122.8, 120.2, 120.1, 119.6, 84.6, 76.5, 54.9, 40.1, 
33.8, 32.6, 29.0, 27.7, 23.4; EI-Mass(m/z): 516.2 (M+). 
3.2.3.3 Synthesis of 1,3,6,8-tetrakis ((9,9’-bis(6-bromohexyl)fluorenyl)ethynyl)pyrene (5) 
1,3,6,8-Tetrabromopyrene (1) (60.0 mg, 0.116 mmol), 4 (430 mg, 0.833 mmol), Pd(PPh3)2Cl2 
(47 mg, 0.067 mmol), CuI (30 mg, 0.16 mmol) and triethylamine (10 mL) were mixed and 
bubbled with nitrogen for 10 min. The mixture was then heated up to 70 °C and stirred 
overnight. After being cooled to room temperature, the mixture was extracted with 
dichloromethane several times. The organic layers were combined and washed with water 
and brine and dried over anhydrous MgSO4. After solvent removal, the crude product was 
purified by silica-gel column chromatography using hexane and dichloromethane (2 : 1) as 
the eluent to afford 5 as a yellow solid (131 mg, 51%). 
1
H NMR (500 MHz, CDCl3) δ (ppm): 
8.93 (s, 4H), 8.60 (s, 2H), 7.79−7.72 (m, 16H), 7.39−7.37 (m, 12H), 3.31−3.28 (t, 16H, J = 
6.93 Hz), 2.08−2.05(m, 16H), 1.71−1.66 (m, 16H), 1.26−1.09 (m, 32H), 0.71−0.66 (m, 16H); 
13
C NMR (125 MHz, CDCl3) ) δ (ppm): 150.73, 150.67, 141.95, 140.40, 133.98, 131.75, 
131.04, 127.81, 127.13, 127.01, 125.97, 124.36, 122.87, 121.46, 120.21, 119.92, 119.26, 
97.36, 88.00, 55.16, 40.26, 33.89, 32.65, 29.06, 27.80, 23.56; EIMass(m/z): 2259.3522 (M+). 
3.2.3.4 Synthesis of 1,3,6,8-tetrakis 
(9,9’-bis(trimethylammoniumhexyl)fluoreneylethynyl))-pyrene octabromide (6) 
Condensed trimethylamine (2 mL) was added dropwise to a solution of 5 (50 mg, 0.022 
mmol) in THF (10 mL) at -78 °C. The mixture was allowed to warm to room temperature and 
stirred for 12 h. The precipitate was redissolved by the addition of methanol (10 mL). After 
the mixture was cooled to -78 °C, additional trimethylamine (2 mL) was added. The mixture 
was stirred at room temperature for 24 h. After solvent removal, acetone was added to 
precipitate 5 as an orange powder in 92% yield. 
1





(s, 4H), 8.72 (s, 2H), 7.98−7.82 (m, 16H), 7.69−7.38 (m, 12H), 3.09−3.05 (m, 16H), 3.07 (s, 
72H), 2.15−2.10 (m, 16H), 1.57−1.53 (m, 16H), 1.14−1.11 (m, 32H), 0.63−0.61 (m, 16H); 
13
C NMR (125 MHz, CD3OD) δ (ppm): 152.38, 152.21, 144.03, 141.92, 133.04, 132.73, 
131.90, 129.41, 128.64, 128.54, 127.57, 124.42, 123.22, 122.58, 121.62, 121.52, 121.18, 
99.49, 88.94, 67.83, 56.68, 53.77, 41.16, 30.31, 27.00, 24.88, 23.78. 
3.2.4 Detection procedures 
3.2.4.1 Fluorescence quenching study 
TFP stock solution (5 µL, 0.2 mM) and PBS buffer (1 mL, 10 mM, pH = 7.4) were 
transferred to a PMMA cuvette (1.5 mL) to yield a solution with [TFP] = 1 µM. GO solution 
(0.039 mg/mL) was subsequently added dropwise at an interval of 2 µL into the cuvette. 
Upon each addition, the mixture was gently mixed 3 times using pipette and then used for PL 
measurements. The PL spectra were collected in the range of 460-700 nm upon excitation at 
380 nm (Figure 3.2B). 
3.2.4.2 Optimization of GO amount for Hep detection 
TFP stock solution (5 µL, 0.2 mM) and PBS buffer (1 mL, 10 mM, pH = 7.4) were 
transferred to a PMMA cuvette (1.5 mL) to yield a solution with [TFP] = 1 µM. HA stock 
solution (10 µL, 2 mM) was then added to yield a final [HA] = 20 µM. GO solution (0.39 
mg/mL) was subsequently added dropwise at an interval of 20 µL into the cuvette. Upon each 
addition, the mixture was gently mixed 3 times using pipette and then used for PL 
measurements. The PL spectra were collected in the range of 460-700 nm upon excitation at 
380 nm. The same experiments were conducted for Hep at [Hep] = 0 or 20 µM. The 
optimized GO concentration is 101.4 mg/L. 
3.2.4.3 Hep quantification 
TFP stock solution (5 µL, 0.2 mM) and PBS buffer (1mL, 10 mM, pH = 7.4) was transferred 





stock solution (2 mM) was then added to yield the final [Hep] = 0, 4, 8, 12, 16 or 20 µM. GO 
solution (0.39 mg/mL) was subsequently added dropwise at an interval of 20 µL into the 
cuvette. Upon each addition, the mixture was gently mixed 3 times using pipette and then 
used for PL measurements. The PL spectra were collected in the range of 460-700 nm upon 
excitation at 380 nm. 
3.3 Results and discussion 
3.3.1 Synthesis and characterization 
The synthetic route towards TFP is depicted in Scheme 3.1. 1,3,6,8-Tetrabromopyrene (1) 
was synthesized by direct bromination of pyrene in nitrobenzene solution with 90% yield. 
156
 
2-Bromo-9,9’-bis(6-bromohexyl) fluorene (2) was prepared according to previous reports,157 
which was coupled with trimethylsilylacetylene via the standard Pd/Cu-catalyzed 
Sonogashira reaction to accord 2-(9,9’-bis(6-bromohexyl)fluorenyl)ethynyltrimethylsilane (3) 
in 56% yield. After removal of trimethylsilyl group in a KOH/THF/methanol solution, 
9,9’-bis(6-bromohexyl)-2-ehtynylfluorene (4) (54% yield) was obtained, which was 
subsequently coupled with 1 under Sonogashira conditions to give the neutral precursor of 
1,3,6.8-tetrakis ((9,9’-bis(6-bromohexyl)fluorenyl)ethynyl)pyrene (5) in 51% yield. Finally, 
1,3,6,8-tetrakis(9,9’-bis(trimethylammoniumhexyl)fluoreneylehtynyl)pyrene octabromide 






























Scheme 3.1 Synthetic route towards TFP. Regents and conditions: a) Br2, 120 °C, 14 h; b) 





H2O, room temperature, 2 h; d) (Ph3P)2PdCl2, CuI, PPh3, Et3N, THF, N2, 70 °C, overnight; e) 
TMA, THF/MeOH, room temperature, 36 h. 
The chemical structures of neutral precursor 5 and TFP were studied by NMR spectra. The 
1
H NMR spectrum of 5 shows signal at 8.93 and 8.60 ppm, which correspond to the aromatic 
protons of pyrene. In addition, the signal peak at 3.14 ppm, assigned to the protons of four 
acetylene groups is not found in the 
1
H NMR spectrum of 5, indicating the successfully 
coupling of ethynylfluorenes to the pyrene core. Comparison of the integrated areas between 
the peaks at 8.93 ppm and 8.60 ppm (the protons of the pyrene core) and that at 3.31-3.28 
ppm (the alkyl protons next to the bromide group of fluorene, -CH2CH2Br) reveals that 
pyrene has been successfully linked to the four fluorene units through the acetylene bridge. 
For the 
1
H NMR spectrum of TFP, the ratio of the integrated area of –CH2N(CH3)3 to that of 
-CH2CH2Br is equal to 4.5, indicating complete quaternization of the bromide. As a result of 
the high charge density, TFP is well dissolved in water with a solubility limit of ~25 mg/mL 
at 24 °C. 
The normalized UV-Vis absorption and PL spectra of TFP in 10 mM phosphate buffered 
saline (PBS, pH = 7.4) are shown in Figure 3.1. Two absorption bands in the region of 





 respectively. The molar extinction coefficients of TFP at 338 and 445 




, respectively. The separated spectral profile is similar 
to other pyrene derivatives reported previously.
160
 The PL spectrum of TFP is vibronic, 
showing an emission maximum at 529 nm. The quantum yield of TFP in 10 mM PBS is 0.39, 
measured using quinine sulfate (ΦF = 0.54, in 0.1 M H2SO4) as standard. TFP is highly 
fluorescent in water, which is much brighter than the commonly-used pyrene derivative of 




















































Figure 3.1 Normalized UV-Vis absorption (black) and PL spectra (red) of TFP in 10 mM 
PBS at pH = 7.4, λex = 380 nm. 
3.3.2 Fluorescence quenching study 
To study the effect of GO on fluorescence quenching of TFP, PL spectra of TFP in the 
absence and presence of GO in PBS buffer were measure, respectively. With the addition of 
GO, a remarkable fluorescence decrease is observed. The fluorescence of TFP is quenched up 
to 97% of its original signal in the presence of 3.5 μg/mL. GO (Figure 3.2A). This high 
quenching efficiency should originate from the combination of strong π-π stacking and 
electrostatic interactions between TFP and GO that induces the formation of tight complexes 
to quench the fluorescence of TFP via an efficient energy/charge transfer process.
155,161
 The 




To quantitatively analyze the quenching of TFP by GO, Stern-Volmer equation (Equation 1.1) 
is applied.  





In this equation, F0 and F are the emission intensities of TFP in the absence and presence of 
GO, respectively; Ksv is the Stern-Volmer constant, which characterizes the quenching 
efficiency of the quencher GO; and [Q] is the concentration of the quencher GO. The change 
in F0/F of TFP with GO concentration is shown in Figure 3.2B. At the low GO concentration 
range (0 – 0.62 μg/mL), F0/F is in linearly proportional to GO concentration, and KSV is 
calculated to be 0.61 (mg/L)
-1
. 









































Figure 3.2 (A) PL spectra of TFP and TFP/GO in 10 mM PBS at pH = 7.4. [TFP] = 1 µM, 
[GO] = 3.5 μg/mL, λex = 380 nm. (B) Stern-Volmer plot of TFP quenched by GO. [TFP] = 1 
µM, [GO] = 0-0.62 μg/mL, λex = 380 nm. 





The fluorescent responses of TFP towards different analytes are studied in 10 mM PBS and 
the corresponding PL spectra are shown in Figure 3.3A. Upon addition of the 20 µM analyte, 
the PL maximum of TFP red-shifted from 529 nm to 534 nm along with an intensity decrease. 
These spectral changes implicate that electrostatic attraction causes complexation between 
TFP and the analytes, which leads to increased local dye concentration to result in TFP 
self-quenching. The PL intensity decreases are 48%, 65%, and 73% for 20 µM each of Hep, 
ChS and HA, respectively. It is obvious that such a fluorescence response is unable to allow 
one to visually discriminate Hep from ChS and HA. 
To improve the selectivity of TFP toward Hep and to realize visual detection of Hep, GO is 
introduced into the assay system. The GO concentration is optimized by monitoring the PL 
spectra of TFP, TFP/Hep, and TFP/HA solution upon addition of GO. The corresponding 
spectral changes are expressed using the intensity ratio of I/I0, where I0 and I are PL 
intensities of TFP at 534 nm in the absence and presence of GO, respectively. As shown in 
Figure 3.3B, with increasing GO concentration, the intensity ratios for both solutions 
gradually decrease, while the decrease rate for TFP/Hep solution is much slower as compared 
to that for TFP/HA solution. This indicates that GO interacts with TFP in both solutions. 
However, the extent of interaction differs to result in different residual fluorescence of TFP. 
As Hep has a much higher charge density than HA does, it has stronger electrostatic 
attractions with TFP. Accordingly, tighter complexation between TFP and Hep could prevent 
GO from contacting with TFP more efficiently as compared to that for HA, ultimately giving 
rise to a smaller PL intensity decrease rate for TFP/GO. Moreover, the largest difference in 
PL intensity between TFP/Hep/GO and TFP/HA/GO is found at [GO] = 101.4 mg/L, wherein 
the PL intensity for TFP/Hep/GO is ~10-fold more intense as compared to that for 
TFP/HA/GO. As a result, 101.4 mg/L of GO is chosen as the optimum GO concentration to 




















































Figure 3.3 (A) PL spectra of TFP, TFP/Hep, TFP/ChS and TFP/HA in 10 mM PBS at pH = 
7.4. [TFP] = 1 μM, [Hep] = [ChS] = [HA] = 20 μM, λex=380 nm. (B) I/I0 as a function of GO 
concentration. [TFP] = 1 μM, [Hep] = [HA] = 20 μM, in 10 mM PBS at pH = 7.4.  
 



































By virtue of the difference in analyte charge density and the analyte/TFP 
interaction-controlled GO quenching; Hep can be visually detected using TFP/GO integrated 
assay according to Scheme 3.2. Addition of negatively charged analytes into TFP solution 
induces the complex formation between TFP and targets. Subsequent addition of GO results 
in binding competition between GO and analytes towards TFP, the extent of which is 
dependent on the charge density of the analytes. In the presence of analytes with low charge 
density (ChS and HA), GO acts as a stronger competitor for the access to TFP, leading to 
greatly quenched fluorescence. In contrast, Hep, with the highest negative charge density of 
any known biomolecules,
162
 can sufficiently prevent the contact between TFP and GO to 
preserve the TFP fluorescence. This detection strategy is confirmed by Figure 3.4A, which 
shows that the PL spectra of TFP in the presence of GO (101.4 mg/L) upon addition of 
different targets (20 µM each) in 10 mM PBS. The PL intensity of TFP/GO/Hep at 535 nm is 
5.4-fold and 10-fold stronger than those of TFP/GO/ChS and TFP/GO/HA, respectively. 
Accordingly, the corresponding solutions emit yellow (Hep), brown (ChS) and no 
fluorescence (HA), respectively (Figure 3.4B), under a hand-held UV lamp, which clearly 
indicates that the developed TFP/GO assay is effective for visual detection of Hep. 

































Figure 3.4 (A) PL spectra of TFP/GO/Hep, TFP/GO/ChS and TFP/GO/HA in 10 mM PBS at 
pH = 7.4. [TFP] = 1 μM, [Hep] = [ChS] = [HA] = 20 μM, [GO] = 101.4 mg/L, λex = 380 nm. 
(B) Photographs of the corresponding fluorescent solutions in Figure 3.4A under UV 
radiation at 365 nm. 
3.3.4 Heparin quantification 
To quantify Hep in solution, the PL intensities of TFP/GO/Hep are correlated to the Hep 
concentration using Equation 2.1, 
  (    )          Equation 2.1 
where I0 and I are the PL intensities at 535 nm in the presence and absence of Hep, 
respectively. The calibration parameter φ is defined to minimize the influence of fluorescence 
background in the absence of Hep. Figure 3.5 shows the φ as a function of Hep concentration 
in 10 mM PBS (pH = 7.4) in the presence of 1 µM TFP and 101.4 µg/mL GO, and its fitting 
line. The plot of φ verses concentration shows a linear calibration in the range of 0-16 µM, 
corresponding to 0-1.76 U/mL. This detection range is suitable for Hep monitoring during 
post-operative and long term care (0.2-1.2 U). The limit of detection (LOD) for Hep in PBS 
buffer is 0.046 U/mL, based on 3 × S0/S, where S0 is standard deviation of background and S 
is the sensitivity. It is worth noting that the detection range of Hep can be expanded by 
increasing the concentrations of TFP and GO used. In comparison with other optical Hep 
assays,
 110, 116, 162





visual sensing capability, making detecting process convenient. This assay also represents 
one of the few that could be used to clearly differentiate Hep from its derivatives. 















Figure 3.5 φ as a function of Hep concentration in 10 mM PBS at pH = 7.4. [TFP] = 1 μM, 
[GO] = 101.4 mg/L, 10 mM PBS (pH = 7.4), λex = 380 nm. 
3.4. Conclusion 
We have synthesized a cationic pyrene-based conjugated oligoelectrolyte (TFP) that emits 
bright fluorescence with quantum yield of 0.39 in buffer solution. Efficient fluorescence 
quenching of TFP by GO occurs due to the electrostatic and π-π interactions, featuring a 
quenching constant of 0.61 (mg/L)
-1
. Although TFP itself is unable to effectively differentiate 
Hep from its analogs, integration of GO into the TFP assay can substantially reduce the 
background signal, ultimately allowing for light-up visual detection of Hep. This 
improvement stems from the interaction-mediated fluorescence quenching of TFP by GO in 
the presence of analytes, which favors high fluorescence for Hep relative to that for ChS and 
HA. Moreover, the linear light-up response of the TFP/GO integrated assay enables precise 
quantification of Hep in the range of 0–1.76 U/mL with a LOD of 0.046 U/mL, which is of 





not only demonstrates a new strategy to extend the biological application of GO, but also 







NAKED-EYE DETECTION AND QUANTIFICATION OF HEPARIN IN 
SERUM WITH A CATIONIC POLYTHIOPHENE 
 
4.1 Introduction 
In Chapter 2, we demonstrated a new BT-containing PF derivative for heparin quantification 
in the whole clinical range. We pointed out that proteins or other biomolecules in the 
complex biological media can cause significant background signals; therefore, this assay can 
only be carried out in buffer solution. In Chapter 3, we further demonstrated a “turn on” type 
label free heparin sensor through integration of TFP and GO. Visual detection of Hep is 
possible as the Hep, ChS and HA solutions emit yellow, brown and no fluorescence, 
respectively. This type of sensor also has the limitation of cannot be operated in complex 
biological media. In addition, both two are fluorometric assays and require addition excitation 
sources (hand-held UV lamp). Therefore, it is highly desirable to develop new assays for 
instrument-free, naked-eye detection and quantification of heparin in complex biological 
media.  
In section 1.4, we reviewed the utilization of cationic, anionic and zwitterionic 
polythiophenes for the detection of nucleic acid, protein, enzyme activity, small biomolecules 
and biomolecule conformational change.
75,76,81,82,163,164
 These water-soluble polythiophenes 
can undergo unique conformational changes upon interacting with different analytes, 
resulting absorbance and solution color changes. In addition, by binding with helical 
biomolecules or asymmetric small molecules, the induced circular dichroism (ICD) signals of 
polythiophene can be observed in the π→π* transition region.75,76,80,82,164,165 
In this chapter, we take advantages of the optical changes of cationic 
poly(1-methyl-3-[2-[(4-methhyl-3-thienyl)oxy]ethyl]-1H-imidazolium) (P4Me-3TOEIM) to 





have also been made to understand the P4Me-3TOEIM/polysaccharides supercomplex 
formation by the use of different techniques and through fine-tuning experimental conditions.  
4.2 Experimental part 
4.2.1 Materials 
All chemicals were purchased from Sigma-Aldrich unless otherwise noted. P4Me-3TOEIM 
was synthesized according to the literature.
76
 The fresh stock solution (2 mM) of 
P4Me-3TOEIM in water was prepared based on repeat unit. Fetal bovine serum (FBS, 
HyClone) was stored at -20 °C and was defreezed at room temperature before use. Hep, ChS, 
HA and Milli-Q water are the same as those in Chapter 2.  
4.2.2 Instruments 
Laser light scattering measurements were performed using a Brookhaven Instruments 
Corporation (BIC) 90 plus instrument with λ = 659 nm at a scattering angle of 90 °. The 
particle diameters were calculated using Zeta Plus Particle Sizing software. Circular 
dichroism spectra were recorded on Jasco J-810 Circular Dichroism Spectropolarimeter 
equipped with a Peltier thermoelectric type temperature control system. The instrument was 
controlled by Jasco’s Spectra Manager software, version 1.53.01. Two channels were used to 
detect circular dichroism and absorption spectra simultaneously. UV-Vis spectrometer is the 
same as that in Chapter 2. The temperature was controlled by Shimadzu temperature 
controller, using “normal” mode. Either a 3 mL quartz cuvette or a 200 µL 8 microcell 
cuvette was used for experiments. Digital camera was the same as that in Chapter 3. 
4.2.3 Detection procedures 
4.2.3.1 Polysaccharide detection at room temperature 
P4Me-3TOEIM stock solution (480 µM, 2 mM) and 2520 µL of water were mixed and 
transferred to a 3 mL quartz cuvette to yield final [P4Me-3TOEIM] = 0.32 mM. 





interval of 3 µL. Upon each addition, the mixture was gently shaken at room temperature 
before UV-Vis measurements. The absorption spectra were collected in the range of 300-700 
nm at room temperature. 
4.2.3.2 Polysaccharide detection at high temperature 
P4Me-3TOEIM stock solution (48 µM, 2 mM) and 252 µL of water were mixed to yield final 
[P4Me-3TOEIM] = 0.32 mM. Polymer solution (100 µL) was added to each microcell and 
the 8-microcell cuvette was warmed up to 70 °C in 5 min. Each polysaccharide (7.5 µL) 
solution (0.8 mM) was then added dropwise to the corresponding microcell at an interval of 
0.5 µL. Upon each addition, the mixture was gently mixed using pipet before UV-Vis 
analysis. The absorption spectra were collected in the range of 300-700 nm at 70 °C. 
4.2.3.3 Laser light scattering measurement (LLS) 
P4Me-3TOEIM stock solution (160 µL, 2 mM), 840 µL of water, and 22.5 µL of heparin or 
chondroitin 4-sulfate stock solution (2 mM) were mixed and transferred to a 3 mL plastic 
cuvette and further diluted with 2000 µL of water to yield a final [P4Me-3TOEIM] = 0.11 
mM and [polysaccharide] = 15 µM. The temperature was set manually from 30 to 70 °C, and 
the data were the average of 8 scans. Control experiments were conducted for each of the 
0.11 mM polythiophene or 15 µM heparin or chondroitin sulfate solution at 30 °C.  In 
addition, LLS for [P4Me-3TOEIM] = 0.11 mM, [Hep] = [ChS] = 15 μM were also studied. 
4.2.3.4 Circular dichroism (CD) measurement 
P4Me-3TOEIM stock solution (480 µL, 2 mM), 2520 µL of water, and 90 µL of heparin or 
chondroitin 4-sulfate stock solution (2 mM) were mixed and transferred to a 3 mL quartz 
cuvette to yield a final [P4Me-3TOEIM] = 0.32 mM and [polysaccharide] = 60 µM. The 
temperature was manually set form 30 to 70 °C, and the scanning speed was 200 nm/minute. 
The CD and absorption spectra were collected in the range of 300-700 nm. 





P4Me-3TOEIM stock solution (480 µL, 2 mM), 1800 µL of methanol, and 720 µL of water 
were mixed and transferred to a 3 mL quartz cuvette to yield a final [P4Me-3TOEIM] = 0.32 
mM. The polysaccharide stock solution (90 µL, 2 mM) was added dropwise at an interval of 
6 µL. Upon each addition, the mixture was gently shaken at room temperature before UV-Vis 
analysis. The absorption spectra were collected in the range of 300-700 nm at room 
temperature. The referenced sample was a mixture of methanol and water (v/v = 3:2). 
4.2.3.6 Polysaccharide detection in fetal bovine serum (FBS) 
The P4Me-3TOEIM stock solution (48 µL, 2 mM), 30 µL of FBS, and 252 µL of water were 
mixed to a final [P4Me-3TOEIM] = 0.32 mM in 10% FBS. The mixture was divided into 
three equal portions and was added to three microcells of an 8-microcell cuvette incubated at 
23 °C for 5 min. Each polysaccharide (0-7.5 µL, 0.8 mM) was added separately to each 
microcell at a 0.5 µL interval. Upon each addition, the mixture was gently mixed using a 
pipet before UV-Vis measurement. The absorption spectra were collected in the range of 
300-700 nm at 23 °C. For high temperature measurement, the same experiments were 
conducted at 70 °C. 
4.3 Results and discussion 
4.3.1 Chemical structure of P4Me-3TOEIM 
The chemical structure of P4Me-3TOEIM is shown in Scheme 4.1. Cationic P4Me-3TOEIM 
was selected as the polymer probe for this study. The conformational change of the polymer 
refers to the transition between a planar form and a nonplanar structure of its backbone. The 
presence of the 4-methyl group on each thiophene ring is essential for the polymer to form a 
planar structure upon complexation with negatively charged molecules. The polymer will 
adopt either a planar or nonplanar conformation according to different types of analytes.
166,167
 
The polysaccharides selected for this study are Hep, ChS and HA (Scheme 2.1). All three 





and one carboxylate group per diasaccharide unit. ChS possesses one sulfate and one 







Scheme 4.1 Chemical structure of P4Me-3TOEIM. 
4.3.2 Optical properties of P4Me-3TOEIM 
The absorption spectra of P4Me-3TOEIM in different media at room temperature (23°C) and 
at 70 °C are shown in Figure 4.1. At room temperature, the polymer has an absorption 
maximum at 393 nm, which corresponds to the random coil conformation of the background 
structure. The increase in absorption at 500 nm in 10% FBS is due to polymer conformation 
changes upon binding to protein mixtures in the medium. When the temperature is increased 
to 70 °C, the absorption maxima slightly blue-shifted for about 5 nm in both water and 10% 
FBS, as compared to that at 23 °C. The polymer absorption maximum remains unchanged in 
a mixture solvent of methanol/water (v/v) = 3:2 at room temperature. Under all conditions, 
the solution color is light yellow. 

































Figure 4.1 Absorption spectra of P4Me-3TOEIM under different conditions. Mixture solvent: 
methanol/water (v/v) = 3:2. 
 





The schematic illustration of heparin detection and quantification is shown in Scheme 4.2. 
One starts with P4Me-3TOEIM in solution. The polymer takes a random coil conformation, 
and the solution color appears light yellow. Addition of negatively charged targets induces 
complexation between the polymer and the targets, the extent of which is dependent on the 
charge density of the analytes. The polymer/analytes complex formation leads to polymer 
conformational changes, which are reflected by spectral shift and solution color variation 
(yellow to orange). Due to different charges and charge arrangement of polysaccharides, the 
binding of P4Me-3TOEIM to the polysaccharides are expected to take different conformation 
and aggregation modes and consequently different colors for heparin and its analogues. 
 
Scheme 4.2 Schematic illustration of heparin detection. 
4.3.4 Polysaccharide detection in water at room temperature 
Titration of P4Me-3TOEIM with Hep in water at room temperature was monitored by 
UV-Vis spectroscopy, and the spectra are shown in Figure 4.2A. In these experiments, 
[P4Me-3TOEIM] = 0.32 mM, and [Hep] varied from 0 to 60 µM at intervals of 2 µM. Upon 
addition of increased amount of heparin, the absorption maximum is gradually shifted to 420 
nm and the absorbance at the longer wavelength gradually increases. An isosbestic point is 
observed at 430 nm. This transformation in the absorption spectra of P4Me-3TOEIM reflects 
the gradually increased conformational change of P4Me-3TOEIM upon P4Me-3TOEIM/Hep 
complex formation. At [Hep = 60 μM, the concentration of negative charges from heparin is 
240 µM, while the concentration of positive charges from P4Me-3TOEIM is 320 µM. Further 





less stable due to more complete charge neutralization of the complexes. The solution color 
changes from yellow to orange accompanying the transition of the spectra, indicating the 
potential application of P4Me-3TOEIM as a colorimetric probe for Hep sensing. 
To study the selectivity of P4Me-3TOEIM toward other polysaccharides, the changes in the 
absorption spectra of P4Me-3TOEIM in the presence of HA and ChS are studied. As shown 
in Figure 4.2B, at [P4Me-3TOEIM] = 0.32 mM, upon addition of 60 µM HA, a very small 
absorption tail is observed at 500 nm and there is almost no bathochromic shift observed. The 
solution remains yellow in the presence of HA. This is simply due to the low charge density 
per disaccharide unit of HA, and the electrostatic attraction between HA and P4Me-3TOEIM 
is significantly weaker than that between Hep and P4Me-3TOEIM. However, upon addition 
of 60 µM ChS to P4Me-3TOEIM, obvious long wavelength absorption peaks at 523 and 576 
nm are observed. These vibronic transitions indicate the formation of intermolecular π 
stacking of the P4Me-3TOEIM/ChS complex.
164,168,169
 Similar to that of Hep, the solution 
color appears orange. These experiments indicate that at room temperature, the polymer can 
only differentiate Hep from HA but not Hep from ChS. As a consequence, two strategies 
have been proposed to solve the problem. One is to add methanol to the detection medium, 
and the other is to increase the detection temperature. 
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Figure 4.2 (A) Absorption spectra of P4Me-3TOEIM at [P4Me-3TOEIM] = 0.32 mM in 
water upon addition of Hep from 0 to 60 µM at intervals of 2 µM. (B) Absorption spectra of 
P4Me-3TOEIM at [P4Me-3TOEIM] = 0.32 mM in water in the presence of [Hep] = [ChS] = 
[HA] = 60 µM. Inset shows the photographs of polymer solutions with 60 µM HA (a), ChS 
(b), and Hep (c). 
 
4.3.5 Polysaccharide detection in methanol/water at room temperature 
Although both methanol and water are good solvents for cationic polythiophenes, they show 
preferred solvation for different parts of polymers. Methanol is a better solvent for the 
hydrophobic backbone with respect to water, while water shows better affinity to the terminal 
charged side chains.
164
 Previous study of folic acid induced polymer aggregation of a cationic 
polythiophene reveals that addition of methanol to the polymer aqueous solution can weaken 
π-π stacking of the polymer backbone due to solubility improvement of the hydrophobic 
moieties.
164
 In this regard, it is reasonable to expect that when the π-π stacking of 
P4Me-3TOEIM within the complexes is reduced, the absorption spectrum of P4Me-3TOEIM 
will change subsequently. Discrimination between Hep and ChS is, thus, studied at room 
temperature in a mixture of methanol and water (v/v = 3:2). As shown in Figure 4.3, when 60 
µM HA, ChS, or Hep is added to 320 µM P4Me-3TOEIM, only Hep shows the long 
wavelength absorption band. There is almost no difference in spectral shape and the 





pure P4Me-3TOEIM. As a consequence, only the solution with Hep shows an orange color 
and others remain light yellow. When one compares Figure 4.3 to Figure 4.2B, it is 
significant that there is almost no obvious change in the absorption spectrum of 
P4Me-3TOEIM/Hep in different media, while the vibronic spectrum for P4Me-3TOEIM/ChS 
disappears in the presence of 60% methanol. 
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Figure 4.3 Absorption spectra of P4Me-3TOEIM in the absence and presence of 60 µM HA, 
ChS, and Hep. [P4Me-3TOEIM] = 0.32 mM, methanol/water (v/v) = 3:2 at room temperature. 
Inset shows the corresponding photographs of polymer solutions with HA (a), ChS (b), and 
Hep (c). 
 
4.3.6 Thermochromic property of P4Me-3TOEIM 
4.3.6.1 Temperature dependent UV-Vis 
The temperature dependent absorption spectra were also studied to understand the thermal 
stability of the complexes formed between P4Me-3TOEIM and different polysaccharides. In 
these studies, the final solutions contain 0.32 mM P4Me-3TOEIM and 60 µM each of HA, 
ChS, or Hep. The absorption spectrum for each solution at 70 °C is shown in Figure 4.4. As 
compared to Figure 4.2B, there is no obvious change observed for P4Me-3TOEIM/Hep 
solution at different temperatures and the solution color remains orange. However, for the 
P4Me-3TOEIM/ChS solution, increasing the solution temperature from 23 to 70 °C 





absorption peaks are almost disappeared at 70 °C. The final solution gives a yellow color, 
which is significantly different from that of P4Me-3TOEIM/Hep. To understand the origin of 
solution spectral change with temperature, laser light scattering and CD spectra were 
collected for each solution. 




























Figure 4.4 Absorption spectra of P4Me-3TOEIM in the absence and presence of 60 µM HA, 
ChS, and Hep at 70 °C in water. [P4Me-3TOEIM] = 0.32 mM. The inset shows the 
corresponding photographs of polymer solutions with HA (a), ChS (b), and Hep (c). 
 
4.3.6.2 Temperature dependent LLS 
Due to the detector response limits, the sample concentration used for LLS study is one-third 
of the absorption study. The LLS for 0.11 mM P4Me-3TOEIM and each of 20 µM Hep and 
ChS was studied first. No signal was found for any solution, which indicated that all starting 
materials were well dissolved in water, with almost no aggregation in solution. The effective 
diameter for the P4Me-3TOEIM/Hep complex was measured to be 125 nm at 30 °C, which 
did not change obviously with the increased temperature (Figure 4.5). On the other hand, 
there was a significant decrease in the size of P4Me-3TOEIM/ChS complex from 225 to 150 
nm when the temperature was increased from 30 to 70 °C. Previous studies on polycations 
and DNA interactions have shown that a reduction in polycation charge density weakens the 
electrostatic attraction between the polymers and DNA, which simultaneously attenuates 
DNA compaction within the complexes.
76





small aggregation is formed for polysaccharides with a higher charge density, which explains 
that the complexes formed between Hep and P4Me-3TOEIM are smaller and more stable 
against temperature variation between 30 to 70 °C. On the other hand, due to the lower 
charge density of ChS, the electrostatic interaction between ChS and P4Me-3TOEIM is 
relatively weaker as compared to that for P4Me-3TOEIM/Hep. The loosely packed 
P4Me-3TOEIM/ChS has a larger aggregation size, and the effective diameter decreases with 
increased temperature. Even at 70 °C, the measurable effective diameter indicates that 
P4Me-3TOEIM/ChS or P4Me-3TOEIM/Hep remain associated with each other through 
electrostatic interaction. 






















Figure 4.5 Effective diameters of Hep/P4Me-3TOEIM and ChS/P4Me-3TOEIM aggregates 
at different temperatures. [P4Me-3TOEIM] = 0.11 mM, [Hep] = [ChS] = 20 µM in pure 
water. 
4.3.6.3 Temperature dependent CD 
To gain more insight into the conformational change of the polymer in 
P4Me-3TOEIM/polysaccharide complexes during heating, temperature dependent CD spectra 
were studied. P4Me-3TOEIM has neither a chiral center nor ordered chain conformation in 
solution. This intrinsic optical inactive property leads to silent CD pattern in the π→π* 
transition region for P4Me-3TOEIM (Figure 4.6A). Due to the asymmetric center of sugar 





visible region. As the CD signal for heparin is below 230 nm,
170
 the results shown in Figure 
4.6A indicate that the introduction of Hep into P4Me-3TOEIM solution results in a split type 
induced circular dichroism (ICD) signal. The sign order of the exciton Cotton effects with a 
long wavelength negative and a short wavelength positive, corresponding to the preferentially 
left-handed helical arrangement of P4Me-3TOEIM in the P4Me-3TOEIM/Hep complex with 
a low intensity at 30 °C. The ICD intensity increases with increased temperature from 30 to 
70 °C, which indicates that the annealing process greatly facilitates the rearrangement of 
P4Me-3TOEIM backbone conformation to adopt a more predominant left-handed helical 
conformation.
75
 On the other hand, as shown in Figure 4.6B, upon addition of ChS to 
P4Me-3TOEIM at 30 °C, the ICD spectrum has shown strong CD bands with vibronic 
structures at the long wavelength. Such a spectroscopy characteristic is generally believed to 
be due to the formation of helical backbone and/or the helical packing of predominantly 
planar chains.
168,171
 With increased temperature, the ICD band intensity for 
P4Me-3TOEIM/ChS decreases and the vibronic bands gradually disappear. It is important to 
note that even at 70 °C, the optically active P4Me-3TOEIM/ChS complex still exhibits 25% 
ICD intensity as compared to that at 30 °C, indicating that the formed complexes remain 
associated, which agrees with the light scattering studies. These results confirm that the 
P4Me-3TOEIM/ChS complexes are destabilized with increased temperature. 






















































Figure 4.6 (A) CD spectra of 0.32 mM P4Me-3TOEIM in water and 0.32 mM 
P4Me-3TOEIM in the presence of 60 µM Hep in water with temperature increased from 30 
to 70 °C. (B) CD spectra of 0.32 mM P4Me-3TOEIM in the presence of 60 µM ChS in water 
with temperature increased from 30 to 70 °C. 
 
4.3.7 Heparin detection in fetal bovine serum medium 
To demonstrate the potential application of the P4Me-3TOEIM probe for heparin detection in 
biological media, 10% FBS solution was used as the medium for further studies. As shown in 
Figure 4.7A, addition of Hep to a 0.32 mM P4Me-3TOEIM solution results in a gradual 
continuous increase in the absorbance at long wavelength. The saturation of the intensity at 
500 nm occurs at [Hep] = 30 µM. Further addition of Hep does not lead to obvious changes 
of the absorbance at long wavelength. The heparin saturation concentration in serum is lower, 
as compared to that shown in Figure 4.2A. This is due to the charge pairing between the 
proteins in serum and P4Me-3TOEIM, which partially blocks the interaction between 
P4Me-3TOEIM and Hep. When the same experiments were conducted for HA and ChS, 
similar spectral characteristics as those shown in Figure 4.2B were observed in serum (Figure 
4.7B). Further increasing the detection temperature from 23 to 70 °C significantly reduces the 
long wavelength absorption for P4Me-3TOEIM/ChS complexes. As shown in the inset of 





results clearly indicate that the cationic P4Me-3TOEIM could be used for naked detection of 
Hep in serum. 


















































































Figure 4.7 (A) Absorption spectra of 0.32 mM P4Me-3TOEIM in 10% FBS upon addition of 





in 10% FBS in the presence of [Hep] = [ChS] = [HA] = 60 µM at (B) 23 °C and (C) 70 °C, 
respectively. The insets show the photographs of P4Me-3TOEIM solutions with 60 µM HA 
(a), ChS (b), and Hep (c) at (B) 23 °C and 70 °C, respectively. 
 
4.3.8 Heparin quantification 
To quantify heparin in solution, the changes in absorption spectra as shown in Figure 4.2A 
and 4.7A are correlated to the analyte concentration using Equation 2.1,  
  (    )    Equation 2.1 
where I0 and I are the absorbance at 500 nm in the presence and absence of Hep, respectively. 
Figure 4.8A,B shows φ as a function of Hep concentration in water and in serum, 
respectively. The calibration factor (φ) is defined to minimize the influence of the absorption 
background in the absence of Hep. Figure 4.8A,B show φ as a function of Hep concentration 
in water and in serum, respectively. The detection range for Hep in water is 0-60 µM, which 
corresponds to 0-6.7 U/mL and covers the majority of the clinical range; while in the 
presence of serum, P4Me-3TOEIM gives a linear response for Hep in 0-20 µM (0-2.2 U/mL), 
which is suitable for heparin monitoring during postoperative and long-term care. In addition, 
the distinguishable colors for polymer solutions at different heparin concentration (insets of 
Figure 4.8A,B) allow naked-eye quantification of heparin in solutions. The limits of detection 
for Hep in water and serum are 0.01 and 0.15 U/mL, respectively, based on 3 × S0/S, where 
S0 is the standard deviation of background and S is the sensitivity. The correlation 
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Figure 4.8 (A) φ as a function of Hep concentration for 0.32 mM P4Me-3TOEIM solution in 
pure water at room temperature. Inset shows the photographs of P4Me-3TOEIM solutions by 
adding 0 (a), 15 (b), 30 (c), 45 (d), and 60 µM (e) heparin in pure water. (B) φ as a function 
of Hep concentration for 0.32 P4Me-3TOEIM solution in 10% FBS at room temperature. 
Inset shows the photographs of P4Me-3TOEIM solutions by adding 0 (a), 10 (b), and 20 µM 
(c) Hep in 10% FBS at 23 °C, respectively. 
 
As compared to the recently reported fluorescent/colorimetric Hep assays (Table 4.1), this 
method represents the first heparin assay that allows instrument-free heparin detection and 
quantification with the naked-eye. In addition, this assay also represents one of the few that 
could be used to clearly differentiate heparin from its derivatives. 
106,112,113
 As compared to 
other conjugated polymer based methods, the assay allows heparin detection and 





heparin quantification range with potential applications in postoperative and long-term care 
after heparin medication. 
receptor method work mode range of quantification 
(U/mL) 
media 
polythiophene (Chapter 4) colorimetric 
(naked-eye) 
 0-6.7 water 
   0-2.2 serum (10%) 
PFBT-20% (Chapter 2) fluorescent(naked-eye 
with UV excitation) 
on 0-8.0 buffer 
TFP/GO (Chapter 3) fluorescent(naked-eye 
with UV excitation) 
on 0-1.76 buffer 
benzimidazolium dyes112 fluorescent on 0-1.2 buffer 
silole derivative111 fluorescent on 0.06-32.5 buffer 
   0-15 horse serum 
(0.4%) 
quinolinium labeled peptide104 fluorescent on 0-0.4 buffer 
tripodal boronic 
acid/pyrocatechol violet106 
colorimetric   buffer 
tripodal boronic acid107 fluorescent off 0.2-9 serum (19%) 
dye labeled protamine105 fluorescent off 0-0.65 buffer 
   0-0.52 bovine plasma 
(10%) 
calyx[8] arene/eosin Y109 fluorescent on 0-20 buffer 
chromophores-tethered 
copolymer108 
fluorescent off 0.075-0.55 buffer 
molecular patterns113 fluorescent on 0-2.0 buffer 
 
Table 4.1 Comparison of fluorescent/colorimetric assays for Hep detection/quantification. 
 
4.4 Conclusion  
In conclusion, we have successfully developed a simple colorimetric assay for heparin 
detection and quantification by taking advantage of the conformational change of a cationic 
polythiophene upon complex formation. Under optimized experimental conditions, the 
polymer has shown distinguishable color difference between Hep and ChS or HA. The 
temperature dependent laser light scattering and CD study further reveals the conformational 
change of the polymer within different complexes with each polysaccharide. The linear 





and accurate heparin quantification in the range of 0 to 60 µM (~6.7 U/mL) in water and from 
0 to 20 µM (~2.2 U/mL) in serum. The most significant advantage of this assay is the 
feasibility of naked-eye detection and quantification of Hep in real time. The assay reported 
herein may find applications in research requiring rapid detection and quantification of 












CP based sensors have been successfully developed for the detection of a wide range of 
biologically important molecules, such as nucleic acids, proteins, enzymes, saccharides and 
lipids.
21,172
 Solubility in aqueous media is often a prerequisite for CPs in these applications. 
The general strategy to yield water-soluble conjugated polymers is to attach anionic 
(sulfonate, carboxylate) or cationic (quaternary ammonium) groups to the CP side chains.
25
 
Solubility of the resulting conjugated polyelectrolytes (CPEs) arises from the preferential 
interactions between ionic groups and water as well as the electrostatic repulsion forces 
between ionic groups. However, CPEs have several intrinsic limitations. Their optical 
properties can be perturbed by the ionic strength and pH change of the media and CPEs may 
nonspecifically interact with interfering molecules, which affects the assay specificity 
(Section 1.6). Nonionic conjugated polymers (NCPs) were subsequently developed through 
attaching highly polar nonionic side chains to mitigate CP backbone interactions. A nonionic 
PPE with its backbone surrounded by polyhydroxylated substituents (PPE-amide-OH, 
Scheme 1.14) was first reported.
27
 Although this polymer is readily soluble in water, its 
quantum yield in aqueous solution (0.07) is much lower than that in organic solvent (0.27 in 
DMF). A practical synthetic method towards an amphiphilic PPE (PPE-bOEG, Scheme 1.14) 
was subsequently demonstrated.
28
 Two branched oligo(ethylene glycol) (OEG) side chains 
were introduced to the monomer unit prior the polymerization step. The polymer is 
water-soluble (0.70 mg·mL
-1
) and its quantum yield in water (0.43) is much higher than that 
of PPE-amide-OH and is comparable to its quantum yields in organic solvents such as 





monomer building block and the wide application of the polycondensation method employed, 
this particular two branched OEG substituted monomer unit was incorporated into different 
PPE type polymers to improve water solubility.
116,117,120-122
 Very recently, an 
end-functionalized nonionic polyfluorene (PF-OEG-B, Scheme 1.14) was reported.
124
 Two 
octakis(ethylene glycol) chains were introduced to the 9, 9’-position of the fluorene unit, and 
the polymer was obtained through the Grignard metathesis polymerization method. The 
polymer is water-soluble and its quantum yield in water (0.8) is comparable to those of other 
PFs. Biotin was introduced to the polymer end and this biotinylated PF can function as an 
energy donor to amplify the signal of Alexa Fluor 488 labeled streptavidin ~5 times. 
Up to now, only few types of NCPs have ever been developed and few have bioapplications. 
Therefore, in this chapter, we demonstrate the synthesis and application of two nonionic 
poly(fluorene-divinylene-phenylene) (PFVP) polymers end capped with protected amine 
groups (P1 and P2, Scheme 5.1). P1 and P2 differ in side chains. P2 with thicker OEG outer 
layer is more water-soluble and has a higher quantum yield in aqueous media. Both P1 and 
P2 are optically stable in high salt solutions, and show minimal nonspecific interactions 
towards bovine serum albumin (BSA), lysozyme and pepsin due to the neutral and 
hydrophilic nature of OEG outer layers. Biotin molecules were then incorporated into 
polymer ends through conventional N-hydroxysuccinimide/amine (NHS/NH2) reaction. The 





























Scheme 5.1. Chemical structures of P1 and P2. 
5.2 Experimental part 
5.2.1 Materials 
All chemicals were purchased from Sigma-Aldrich unless otherwise noted. HCl (4 M) in 
anhydrous dioxane was purchased from Alfa Aesar. Undecaethylene glycol monomethyl 
ether (mOEG-11, 97%) was purchased from Biomatrik Inc. High Capacity Streptavidin 
Agarose Resin was purchased from Pierce Biotechnology. Cy5 labeled streptavidin (Cy5-SA) 
was purchased from eBioscience. 
2,7-Dibromo-9,9-bis({2-[2-(2-bromoethoxy)ethoxy]ethyl})-9H-fluorene (1), 
2,5,8,11,14,17,20,23,26,29,32-undecaoxatetratriacontan-34-yl 4-methylbenzene-1-sulfonate 
(9) and 1,4-divinylbenzene (15) were synthesized according to literature procedures.
62,173,174
 
Anhydrous dichloromethane was prepared by distillation from calcium hydride and 
anhydrous tetrahydrofuran (THF) was prepared by distillation from sodium/benzophenone 
prior to use. The stock solutions of P1, P2, P1-NH2, P2-NH2, P1-B, P2-B in methanol were 
prepared based on repeat unit ([RU] = 1 mM, the molecular weights of one repeat unit for P1 





stock solutions ([RU] = 1mM) of P1-NH2, P1-B in water were prepared by first dissolving 
polymers in methanol, then dialyzing against water for two days and finally adjusting the 
polymer concentration using UV-Vis measurements. The stock solutions ([RU] = 1 mM) of 
P2- NH2, P2-B in water were prepared by direct dissolving polymers in water. The polymer 
stock solutions were stored at 4 °C. Solutions of sodium dodecyl sulfate (SDS) and 
dodecyltrimethylammonium bromide (DoTAB) were prepared at least 1 day before 
experiments, and the solutions were stored at room temperature. Milli-Q water (18.2 MΩ.cm 
at 25 °C) was used for experiments. 
5.2.2 Instruments 
The NMR spectra were recorded on a Bruker Avance 500 (DRX 500, 500 MHz) 
spectrometer using deuterated chloroform or methanol as solvent and tetramethylsilane as 
internal standard. GPC instrument is the same as that in Chapter 2. Monodisperse polystyrene 
samples were used for calibration and N,N-dimethylformamide (DMF) containing 50 mM 
lithium bromide was used as the mobile phase at a flow rate of 1.0 mL·min
-1
 at 35°C. UV-Vis 
spectrometer and fluorometer are the same as those in Chapter 2. All UV-Vis and PL spectra 
were collected at 24 ± 1 °C. Fluorescence quantum yields (ΦF) were measured using quinine 
sulfate (ΦF = 0.54, in 0.1 M H2SO4) as standard. Laser light scattering measurements were 
performed on the same BIC plus instrument as that in Chapter 4. Photographs were taken 
using a Canon EOS 450D digital camera under a hand-held UV-lamp with λex = 365 nm. 
Fisher brand regenerated cellulose dialysis tubing with 12-14 kDa molecular weight cutoff 












1 (2.20 g, 3.08 mmol), anhydrous DMF (20.0 mL), anhydrous THF (10.0 mL), anhydrous 
potassium carbonate (2.17 g, 15.7 mmol) and propionic acid (1.14 g, 15.4 mmol) were mixed 
and stirred under argon at 90 ˚C overnight. After cooling to room temperature, the reaction 
mixture was poured into water (100.0 mL) and extracted with ethyl acetate (3 × 50.0 mL). 
The organic layers were combined and dried over anhydrous MgSO4 and filtered. After 
solvent removal, the crude product was purified by silica-gel column chromatography using 
hexane and ethyl acetate (2 : 1) as eluent to yield a colorless oil (1.88 g, 87.1%). 
1
H NMR 
(500 MHz, CDCl3): δ 7.47 – 7.40 (m, 6H), 4.10 (t, 4H, J = 4.50 Hz), 3.51 (t, 4H, J = 5.00 Hz), 
3.32 (t, 4H, J = 4.50 Hz), 3.13 (t, 4H, J = 5.00 Hz), 2.73 (t, 4H, J = 7.50 Hz), 2.29 – 2.24 (m, 
8H), 1.06 (t, 6H, J = 7.50 Hz). 
13
C NMR (125 MHz, CDCl3): δ 174.41, 150.94, 138.47, 
130.68, 126.74, 121.64, 121.23, 70.35, 69.18, 66.83, 63.39, 51.94, 39.49, 27.46, 9.07. EI 
Mass (m/z): calcd for C31H40Br2O8, 698.1; found: 698.3. 
5.2.3.2 Synthesis of 
2-{2-[2-(2,7-dibromo-9-{2-[2-(2-hydroxy-ethoxy)-ethoxy]-ethyl}-9H-fluoren-9-yl)-ethoxy]-et
hoxy}-ethanol (3) 
2 (1.40 g, 2.00 mmol), acetone (35.0 mL), water (35.0 mL) and sodium hydroxide (400 mg, 
10.0 mmol) were mixed and stirred at 80 ˚C for 4 hours. The organic solvent was removed 
and the residue was diluted with water (50.0 mL) and extracted with ethyl acetate (3 × 50.0 
mL). The organic layers were combined and dried over anhydrous MgSO4 and filtered. After 
solvent removal, the crude product was purified by silica-gel column chromatography using 
first ethyl acetate and then acetone to yield a colorless oil (1.12 g, 95.2%). 
1
H NMR (500 





3.37 (t, 4H, J = 4.50 Hz), 3.17 (t, 4H, J = 5.00 Hz), 2.78 (t, 4H, J = 7.00 Hz), 2.31 (s, 2H), 
2.27 (t, 4H, J = 7.50 Hz).
13
C NMR (125 MHz, CDCl3): δ 151.02, 138.39, 130.73, 126.83, 
121.69, 121.27, 72.50, 70.25, 70.15, 67.03, 61.72, 52.04, 39.20. EI Mass (m/z): calcd for 
C25H32Br2O6, 586.1; found: 586.2. 
5.2.3.3 Synthesis of 
2-[2-(2-{2,7-dibromo-9-[2-(2-{2-[(4-methylbenzenesulfonyl)methoxy]ethoxy}ethoxy)ethyl]-9
H-fluoren-9-yl}ethoxy)ethoxy]ethyl 4-methylbenzene-1-sulfonate (4) 
3 (637 mg, 1.08 mmol), sodium hydroxide (405 mg, 10.1 mmol), water (2.2 mL), THF (2.6 
mL) were mixed and stirred at 0 °C. p-Toluenesulfonyl chloride (600 mg, 3.15 mmol) in THF 
(2.5 mL) was added slowly in 20 minutes. The reaction was stirred at 0 °C for 2 hours and 
was then allowed to warm up to room temperature and continued overnight. The organic 
solvent was removed and the residue was diluted with water (50.0 mL) and extracted with 
dichloromethane (3 × 50.0 mL). The organic layers were combined and dried over anhydrous 
MgSO4 and filtered. After solvent removal, the crude product was purified by silica-gel 
column chromatography using hexane and ethyl acetate (1 : 1) as eluent to yield a colorless 
liquid (905 mg, 93.3%). 
1
H NMR (500 MHz, CDCl3): δ 7.70 – 7.69 (d, 4H), 7.45 – 7.38 (m, 
6H), 7.25 – 7.23 (d, 4H), 4.02 (t, 4H, J = 5.00 Hz), 3.48 (t, 4H, J = 5.00 Hz), 3.23 (t, 4H, J = 
5.00 Hz), 3.03 (t, 4H, J = 5.00 Hz), 2.68 (t, 4H, J = 7.00 Hz), 2.35 (s, 6H), 2.34 (t, 4H, J = 
7.50 Hz). 
13
C NMR (125 MHz, CDCl3): δ 150.92, 144.78, 138.49. 133.00, 130.70, 129.81, 
127.99, 126.71, 121.62, 121.31, 70.55, 69.98, 69.22, 68.67, 66.84, 51.95, 39.47, 21.66. EI 
Mass (m/z): calcd for C39H44Br2O10S2, 894.1; found: 894.4. 







mOEG-11 (770 mg, 1.49 mmol) in anhydrous THF (2.0 mL) and potassium tert-butoxide (1.6 
mL, 1M in anhydrous THF) were mixed and stirred under argon at 0 °C for 10 minutes, 4 
(504 mg, 0.562 mmol) in anhydrous THF (10.0 mL) was added, and the reaction continued at 
room temperature overnight. The organic solvent was removed and the residue was diluted 
with water (75.0 mL) and extracted with dichloromethane (3 × 75.0 mL). The organic layers 
were combined and dried over anhydrous MgSO4 and filtered. After solvent removal, the 
crude product was purified by silica-gel column chromatography using dichloromethane and 
methanol (100 : 2) as eluent to yield a colorless liquid (594 mg, 66.7%). 
1
H NMR (500 MHz, 
CDCl3): δ 7.53 – 7.45 (m, 6H), 3.68 – 3.50 (m, 100H), 3.37 (s, 6H), 3.18 (t, 4H, J = 5.00 Hz), 
2.76 (t, 4H, J = 7.5 Hz), 2.33 (t, 4H, J = 7.5 Hz). 
13
C NMR (125 MHz, CDCl3): δ 150.92, 
138.45, 130.65, 126.68, 121.61, 121.23, 71.92, 70.55, 70.49, 70.36, 70.02, 66.75, 59.00, 
51.89, 39.46. ESI Mass (m/z): calcd for C71H124Br2O28Na, 1605.7; found: 1605.7. 
5.2.3.5 Synthesis of 2,7-dibromo-9,9-bis-(3,5-dimethoxy-benzyl)-9H-fluorene (7) 
2,7-Dibromofluorene (6) (2.80 g, 8.64 mmol), tetrabutylammonium bromide (224 mg, 6.95 
mmol) and dimethyl sulfoxide (DMSO, 40.0 mL) were mixed and stirred for 5 minutes. KOH 
aqueous solution (50% w/w, 4.0 mL) was added followed by the addition of 
3,5-dimethoxybenzyl bromide (4.80 g, 20.8 mmol). The reaction was continued at room 
temperature overnight. The reaction mixture was then poured slowly into water (150.0 mL) 
and extracted with dichloromethane (3 × 75.0 mL). The organic layers were combined, dried 
over anhydrous MgSO4 and filtered. After solvent removal, the crude product was purified by 
silica-gel column chromatography using hexane and dichloromethane (1 : 1) as eluent to 
yield a white solid (4.05 g, 75.1%).
1
H NMR (500 MHz, CDCl3): δ 7.58 – 7.25 (m, 6H), 6.13 
(t, 2H), 5.83 (d, 4H), 3.53 (s, 12H), 3.27 (s, 4H). 
13
C NMR (125 MHz, CDCl3): δ 159.70, 
150.34, 138.94, 138.20, 130.42, 127.99, 121.46, 120.44, 107.95, 99.58, 57.12, 55.10, 45.45. 





5.2.3.6 Synthesis of 
5-({2,7-dibromo-9-[(3,5-dihydroxyphenyl)methyl]-9H-fluoren-9-yl}methyl)benzene-1,3-diol 
(8) 
7 (1.30 g, 2.08 mmol) was dissolved in anhydrous dichloromethane (20.0 mL) under argon. 
The solution was then cooled to -78 °C using dry ice/acetone bath and boron tribromide (6.1 
mL, 63 mmol) was added slowly in 30 minutes. After 4 hours, the reaction was allowed to 
warm up to room temperature and continued for 36 hours. The reaction flask was placed into 
an ice bath and water (125.0 mL) was added very slowly to quench the reaction. The solution 
was then extracted with ethyl acetate (3 × 75.0 mL). The organic layers were combined, dried 
over anhydrous MgSO4 and filtered. After solvent removal, the crude product was purified by 
silica-gel column chromatography using ethyl acetate and hexane (1 : 2) as eluent to yield a 
white solid (956 mg, 80.8%).
1
H NMR (500 MHz, d4-MeOH): δ 7.59 – 7.17 (m, 6H), 5.93 – 
5.92 (t, 2H), 5.69 – 5.69 (d, 4H), 3.36 (s, 4H), 3.35 (s, 4H). 13C NMR (125 MHz, d4-MeOH): 
156.91, 150.74, 138.97, 130.08, 127.82, 121.07, 120.22, 108.86, 100.25, 58.81, 45.02. EI 
Mass (m/z): calcd for C27H20Br2O4, 566.0; found: 566.1. 





8 (277 mg, 0.487 mmol), 9 (1.44 g, 2.15 mmol), potassium carbonate (810 mg, 5.68 mmol) 
and acetone (40.0 mL) were mixed and stirred under argon at 70 °C for 48 hours. The 
mixture was then allowed to cool to room temperature. The organic solvent was removed and 
the residue was diluted with water (50.0 mL) and extracted with dichloromethane (3× 50.0 





solvent removal, the crude product was purified by silica-gel column chromatography using 
methanol and dichloromethane (first 2: 100, then 10 : 100) as eluent to yield a colorless liquid 
(1.12 g, 89.7%).
1
H NMR (500 MHz, CDCl3): δ 7.51 – 7.28 (m, 6H), 6.16 (t, 2H), 5.81 (d, 
4H), 3.80 – 3.78 (m, 8H), 3.73 – 3.64 (m, 160H), 3.55 – 3.53 (m, 8H), 3.37 (s, 12H), 3.21 (s, 
4H). 
13
C NMR (125 MHz, CDCl3): δ 158.73, 150.34, 138.82, 137.94, 130.37, 127.92, 121.45, 
120.38, 108.80, 100.99, 72.59, 71.86, 70.62, 70.49, 70.43, 70.22, 69.48, 67.25, 61.55, 58.95, 
56.97, 45.27. ESI Mass (m/z): calcd for C119H204Br2O48Na, 2582.2; found: 2582.2. 
5.2.3.8 Synthesis of 2-(4-bromo-butyl)-isoindole-1,3-dione (11) 
Potassium phthalimide (10.40 g, 56.15 mmol), 1,4-dibromobutane (24.30 g, 112.5 mmol) and 
acetone (120.0 mL) were mixed and stirred at 50 ºC for 24 hours. After solvent removal, the 
crude product was purified by silica-gel column chromatography using hexane and 
dichloromethane (1:1) followed by dichloromethane as eluent to yield a white solid (6.16 g, 
39.0%). 
1
H NMR (500 MHz, CDCl3) δ 7.85 – 7.84 (m, 2H), 7.73 – 7.71 (m, 2H), 3.73 (t, 2H, 
J = 6.5 Hz), 3.44 (t, 2H, J = 6 Hz), 1.92 – 1.84 (m, 4H). 13C NMR (125 MHz, CDCl3): δ 
168.35, 133.99, 132.07, 123.26, 36.96, 32.77, 29.86, 27.25. EI Mass (m/z): calcd for 
C12H12BrNO2 281.1; found: 281.0. 
5.2.3.9 Synthesis of 2-[4-(4-bromo-phenoxy)-butyl]-isoindole-1,3-dione (12) 
4-Bromophenol (3.68 g, 21.3 mmol), 11 (5.00 g, 17.7 mmol), potassium carbonate (8.80 g, 
63.7 mmol), [18]-crown-6 (210 mg, 0.796 mmol) and acetone (80.0 mL) were mixed and 
stirred under nitrogen at 70 °C overnight. The solvent was removed and the residue was 
diluted with dichloromethane (200.0 mL), washed with water (3 × 75.0 mL), dried over 
anhydrous MgSO4 and filtered. After solvent removal, the crude product was purified by 
silica-gel column chromatography using dichloromethane and hexane (2 :1) as eluent to yield 
a white solid (4.55 g, 68.8 %). 
1
H NMR (500 MHz, CDCl3) δ 7.85 – 7.83 (m, 2H), 7.73 – 





8.5 Hz), 1.92 – 1.79 (m, 4H). 13C NMR (125 MHz, CDCl3): δ 168.39, 157.94, 133.914, 
132.14, 132.02, 123.18, 116.24, 112.70, 67.32, 37.53, 26.45, 25.20. EI Mass (m/z): calcd for 
C18H16BrNO3, 373.0; found: 373.1. 
5.2.3.10 Synthesis of 4-(4-bromo-phenoxy)-butylamine (13) 
12 (3.00 g, 8.02 mmol) was dissolved in a mixture of ethanol (75.0 mL) and toluene (25.0 mL) 
under nitrogen, followed by addition of hydrazine monohydrate (3.9 mL, 81 mmol). The 
reaction was refluxed at 60 °C overnight. The white precipitate formed during the reaction 
was removed by filtration. The filtrate was concentrated and the residue was diluted by 
dichloromethane (200.0 mL). The organic layer was washed with 1M NaOH (2 × 50.0 mL) 
and dried over anhydrous MgSO4 and filtered. After solvent removal, the crude product was 
purified by silica-gel column chromatography using ethyl acetate followed by acetone as 
eluent to yield a colorless oil (1.44 g, 73.6%). 
1
H NMR (500 MHz, CDCl3): δ 7.33 – 7.31 (d, 
2H), 6.73 – 6.72 (d, 2H), 3.89 (t, 2H, J = 6.00 Hz), 2.72 (t, 2H, J = 7.00 Hz), 1.79 – 1.74 (m, 
2H), 1.60 – 1.54 (m, 2H), 1.48 (br, 2H). 13C NMR (125 MHz, CDCl3): δ 158.11, 132.19, 
116.27, 112.64, 67.98, 41.87, 30.22, 26.57. EI Mass (m/z): calcd for C10H14BrNO, 243.0; 
found: 243.0. 
5.2.3.11 Synthesis of [4-(4-bromo-phenoxy)-butyl]-carbamic acid tert-butyl ester (14) 
13 (195 mg, 0.799 mmol), di-tert-butyl dicarbonate (208 mg, 0.954 mmol), NaOH (2M, 1.6 
mL), dioxane (1.6 mL) and water (0.8 mL) were mixed and stirred under 0 °C for 4 hours. 
The reaction was then allowed to warm to room temperature and continued overnight. The 
reaction mixture was diluted with water (20.0 mL) and extracted with ethyl acetate (2 × 50.0 
mL). The organic layers were combined, dried over anhydrous MgSO4 and filtered. After 
solvent removal, the crude product was purified by silica-gel column chromatography using 
ethyl acetate and hexane (1 : 3) as eluent to yield a white solid (208 mg,  75.6%). 
1
H NMR 





6.00 Hz), 3.19-3.18 (d, 2H), 1.83 – 1.77 (q, 2H), 1.68 – 1.63 (q, 2H), 1.44 (s, 9H). 13C NMR 
(125 MHz, CDCl3): δ 157.97, 155.95, 132.17, 116.22, 112.70, 67.66, 40.19, 28.38, 26.75, 
26.42. EI Mass (m/z): calcd for C15H22BrNO3, 343.1; found, 343.1. 
5.2.3.12 Synthesis of PFVP-2OEG-BocNH2 (P1) 
A Schlenk tube was charged with 5 (141 mg, 0.0889 mmol), 1,4-divinylbenzene (15) (11.6 
mg, 0.0889 mmol), palladium (II) acetate (1.5 mg, 6.7 µmol) and tris(o-tolyl)phosphine (9.0 
mg, 0.030 mmol) before it was degassed with vacuum-argon cycles to remove air. 
N,N-diisopropylethylamine (0.5 mL) and DMF (1.0 mL) was subsequently added to the 
Schlenk tube and the mixture was frozen, evacuated and thawed three times to further remove 
air. The mixture was stirred and heated at 103 °C for 2 hours under argon. Then, 
1,4-divinylbenzene (15) (3.0 mg, 0.023 mmol) was transferred to a small tube containing 
DMF (0.5 mL). The solution was frozen, evacuated and thawed three times to remove air, 
and was transferred via needle to the Schlenk tube for polymerization. The reaction was 
allowed to continue at 103 °C for 6 hours. 14 (31.7 mg, 0.0922 mmol), palladium (II) acetate 
(0.75 mg, 3.3 µmol) and tris(o-tolyl)phosphine (4.5 mg, 0.15 mmol) were transferred to a 
small tube containing DMF (0.5 mL). The mixture was frozen, evacuated and thawed three 
times to remove air. The solution was transferred via needle to the polymerization reaction 
mixture. The reaction was allowed to continue at 103 °C overnight. The mixture was cooled 
to room temperature and dialyzed against water for three days. The residue in the dialysis 
tube was collected and filtered to yield a clear greenish colored solution. After freeze-drying, 
the yellow oil was redissolved in DCM and precipitated in ethyl ether. P1 (113 mg, 81.7%) 
was obtained as a yellowish waxy compound. 
1
H NMR (500 MHz, CDCl3): δ7.80 – 7.12 (m, 
14H), 3.71 – 3.48 (m, 96H), 3.34 (br, 4H), 3.30 (s, 6H), 3.16 (br, 4H), 2.76 (br, 4H), 2.39 (br, 
4H).
 13
C NMR (125 MHz, CDCl3): δ 149.2, 139.79, 136.62, 128.64, 127.96, 126.80, 126.47, 





5.2.3.13 Synthesis of PFVP-4OEG-BocNH2 (P2) 
Polymerization between 10 (197 mg, 0.0769 mmol) and 1,4-divinylbenzene (15) (10.0 mg, 
0.0769 mmol) for 4 hours following the same procedures as that for P1 yielded P2 (147 mg, 
75.4%) as a green-yellowish waxy compound. 
1
H NMR (500 MHz, CDCl3): δ 7.81 – 6.67 (m, 
14H), 6.24 – 5.71 (m, 6H), 3.71 (br, 8H), 3.56 – 3.43 (m, 172H), 3.30 (s, 12H). 13C NMR 
(125 MHz, CDCl3): δ 158.62, 140.22, 138.94, 136.63, 136.31, 128.78, 127.67, 126.70, 
126.48, 126.27, 120.10, 109.04, 100.71, 71.79, 70.42, 69.37, 67.11, 58.86, 55.95, 45.40. 
5.2.3.14 Synthesis of PFVP-2OEG-NH2 (P1-NH2) 
P1 (40 mg, 0.026 mmol) was dissolved in HCl (4 M) in anhydrous dioxane (4.0 mL) and the 
solution was stirred under nitrogen at room temperature for 6 hours in the dark. The reaction 
flask was then placed into an ice bath and 2M potassium carbonate was added slowly to 
adjust pH to 7. Dioxane was removed through rotary evaporation, and the residue was 
dialyzed against water for three days. After freeze drying, P1-NH2 (32.2 mg, 80.5%) was 
obtained as a yellowish waxy compound. 
1
H NMR (500 MHz, CDCl3): δ 7.81 – 7.02 (m, 
14H), 3.61 – 3.52 (m. 96H), 3.36 (br, 4H), 3.35 (s, 6H), 3.20 (br, 4H), 2.80 (br, 4H), 2.44 (br, 
4H).  
5.2.3.15 Synthesis of PFVP-4OEG-NH2 (P2-NH2) 
P2-NH2 was obtained as a green-yellowish waxy compound (35.4 mg, 88.5%) following the 
same procedure as that for P1-NH2. 
1
H NMR (500 MHz, CDCl3): δ 7.75 – 6.88 (m, 14H), 
6.33 – 5.70 (m, 6H), 3.74 (br, 8H), 3.61 – 3.46 (m, 172H), 3.33 (s, 12H). 
5.2.3.16 Synthesis of PFVP-2OEG-Biotin (P1-B) 
P1-NH2 (10.0 mg, 6.43 µmol) was dissolved in anhydrous DMF (1.0 mL), (+)-biotin 
N-hydroxysuccinimide ester (NHS-biotin, 1.0 mg, 2.9 mmol) in anhydrous DMF (100 µL) 
was added quickly and the reaction was continued overnight under nitrogen at room 





P1-B (8.0 mg, 80%) was obtained. 
1
H NMR (500 MHz, CDCl3): δ 7.78 – 7.05 (m, 14H), 3.80 
– 3.50 (m, 96H), 3.39 – 3.37 (m, 4H), 3.35 (s, 6H), 3.21 (br, 4H), 2.80 (br, 4H), 2.44 (br, 4H).  
5.2.3.17 Synthesis of PFVP-4OEG-Biotin (P2-B) 
P2-B (9.1 mg, 91%) was obtained following the same procedures as that for P1-B. 
1
H NMR 
(500 MHz, CDCl3): δ 7.66 – 6.81 (m, 14H), 6.14 – 5.64 (m, 6H), 3.71 (br, 8H), 3.65 – 3.40 
(m, 172H), 3.30 (s, 12H). 
5.2.4 P1-B, streptavidin agarose resin binding 
Streptavidin agarose resin (100 µL, 50% slurry) was transferred to a 1.5 mL micro-centrifuge 
tube and was centrifuged at 2500 rpm for 2 min. Supernatant was removed and the resin was 
washed with a washing buffer (1 × PBS buffer containing 1% (v/v) Tween-20, pH = 7.4, 
1000 µL) twice. In between the washing steps, the resin was redispersed in the washing 
buffer by shaking at 600 rpm for 5 min at room temperature. The resin was then resuspended 
in P1-B, [RU] = 0.50 mM in 1000 µL washing buffer and was shaken at 600 rpm overnight 
(4 °C). UV-Vis measurement showed that the absorption spectrum of P1-B, [RU] = 0.50 mM 
in washing buffer was identical to that of P1-B, [RU] = 0.50 mM in water. The resin 
suspension was then centrifuged and washed five times with the washing buffer. The 
supernatants were collected and combined. The concentration of the supernatant was obtained 
through UV-Vis measurement. The overall amount of P1-B bound to the resin was then 
calculated. Parallel experiment was conducted using P1-NH2 as a control under the same 
experimental conditions.  
5.2.5 P2-B, streptavidin agarose resin binding  
Resin was treated with P2-B following the same procedure as that for P1-B as demonstrated 
in 5.2.4. Parallel experiment was conducted using P2-NH2 as a control.  





Cy5-SA (5 µL, 0.04 mg·mL
-1
) was mixed with P1-B (0, 1, 2, 3, 4 or 5 µL, [RU] = 0.5 mM) 
in 1 × PBS buffer (pH = 7.4) in a 1 mL tube to a final volume of 25 μL. The mixture was 
shaken at 800 rpm for 20 min at room temperature. The solution was then diluted by 2975 µL 
of 1 × PBS buffer (pH = 7.4), and the emission spectra were collected upon excitation at 438 
nm. Cy5-SA was incubated with P1-NH2, P2-B and P2-NH2 following the same procedures. 
The excitation wavelengths were 438nm, 434 nm and 434nm, respectively.  
5.3 Results and discussion 
5.3.1 Synthesis and characterization 
The synthetic route towards monomer 5 is depicted in Scheme 5.2. Compound 1 was 
prepared according to literature procedure.
62
 Reaction between 1 and excess amount of 
propionic acid in the presence of potassium carbonate in anhydrous DMF/THF solution 
afforded carboxylic ester 2 as a colorless liquid in 87.1% yield.
176
 Hydrolysis of 2 in aq 
NaOH/acetone afforded compound 3 in 95.2% yield,
176
 which was subsequently reacted with 
p-toluenesulfonyl chloride in aq NaOH/THF to yield its sulfonate ester 4 in 93.3% yield. 
Finally, monomer 5 was obtained in 66.7% yield through substitution reaction of mOEG-11 
with 4. Attempts were also made to synthesis monomer 5 via direct Williamson ether 
synthesis method by substituting two bromides in the ends of monomer 1 side chains with 
mOEG-11.
177
 However, thin layer chromatography (TLC) analysis showed that mostly 
mono-substituted product was obtained even after one week reaction. 
The synthetic route towards monomer 10 is depicted in Scheme 5.2. The starting material 
2,7-dibromofluorene (6) was alkylated with 3,5-dimethoxybenzyl bromide in the presence of 
50% w/v KOH as base and tetrabutylammonium bromide as phase transfer catalyst in DMSO 
to produce 7 as a white solid in 75.1% yield. All aromatic methyl ether bonds of 7 were 





group of mOEG-11 was converted to sulfonate ester group (9) according to literature 
procedure,
173
 and excess amount of 9 was used to react with 8 to give 10 as a colorless liquid 
in 89.7% yield.  
The synthetic route towards end capper 14 is depicted in Scheme 5.2. Potassium phthalimide 
was alkylated with excess amount of 1,4-dibromobutane to give 11 as a white solid in 39.0% 
yield. Phenyl bromide group was subsequently introduced through substitution reaction 
between 4-bromophoenol and 11 using [18]-crown-6 as phase transfer catalyst and potassium 
carbonate as base to give 12 as a white solid in 68.8% yield. Phthalimide group of 12 was 
removed using ethanolic hydrazine under reflux conditions to afford 13 as a colorless liquid 
in 73.6% yield. The primary amine of 13 was protected under aqueous conditions using 
di-tert-butyl dicarbonate in the presence of NaOH in dioxane to form t-Boc derivative 14 as a 
white solid in 75.6% yield. 14 is composed of a phenyl bromide group for polymer end 
capping, a t-Boc protected amine which is stable under base conditions and can be easily 














































































K2CO3, DMF/THF, 90 °C, overnight; b) NaOH, acetone/water, 80 °C, 4 h; c) 
p-toluenesulfonyl chloride, NaOH, THF/water, 0 °C to room temperature, overnight; d) 
mOEG-11, potassium tert-butoxide, THF, room temperature, overnight; e) 
tetrabutylammonium bromide, 3,5-dimethoxybenzyl bromide, KOH, DMSO/water , room 
temperature, overnight; f) boron tribromide, DCM, -78 °C to room temperature, 40 h; g) 
K2CO3, acetone, 70 °C , 48 h; h) potassium phthalimide, acetone, 50 °C, 24 h; i) 
4-bromophenol, K2CO3, [18]-crown-6, acetone, 70 °C, overnight; j) hydrazine monohydrate, 
toluene/ethanol, 60 °C, overnight; k) di-tert-butyl dicarbonate, NaOH, dioxane/water, 0 °C to 
room temperature, overnight. 
As shown in Scheme 5.3, the polymers P1 and P2 were synthesized via Heck 
polycondensation between monomers 5, 10 and 1,4-divinylbenzene (15) in the presence of 
palladium (II) acetate, tris(o-tolyl)phosphine and N,N-diisopropylethylamine at 103 °C in 
DMF for 2 or 4 hours, respectively. Monomer 15 was then added and the reaction was 
continued for 6 hours. Compound 14 with additional palladium catalyst was further added to 
cap the polymer ends. The polymers were purified by dialysis against Milli-Q water using 
12,000 – 14,000 Da molecular weight cutoff dialysis membrane for 3 days, filtration, 
freeze-drying and finally precipitation in diethyl ether to obtain waxy compounds (P1, 81.7%; 
P2, 75.4%). P1-NH2 (80.5%) and P2-NH2 (88.5%) were obtained through deprotection of 
amine groups of P1 and P2 under anhydrous acidic conditions. Biotin was introduced through 
conventional NHS/NH2 reaction between biotin N-succinimidyl ester (NHS-biotin) and P1- 






















P1-NH2 or P2-NH2: R =
O
NH2


























5.3 Synthetic route towards P1-B and P2-B. Regents and conditions: a) palladium (II) acetate, 
tris(o-tolyl)phosphine , N,N-diisopropylethylamine, DMF, 103 °C, 2 h or 4 h; b) 15, DMF, 
103 °C, 6 h; c) 14, palladium (II) acetate, tris(o-tolyl)phosphine , DMF, 103 °C, overnight; d) 
HCl, dioxane, room temperature, 6 h; e) NHS-biotin, DMF, room temperature, overnight.  
The chemical structures of monomers 5 and 10 were studied by NMR spectra. The 
1
HNMR 
of 5 shows multiple peaks from 7.53 to 7.45 ppm, which correspond to the aromatic protons 
of the fluorene unit. The singlet peak at 3.37 ppm appears, and is assigned to the protons of 
methyl groups of the side chains. Comparison of the integrated areas between the peaks from 
7.53 to 7.45 ppm (the protons of fluorene unit) and that at 3.37 ppm (the protons of the 
methyl groups CH2CH2OCH3) reveals that two side chains have been successfully introduced 
to the fluorene unit. The 
1
HNMR of 10 shows multiple peaks from 7.51 to 5.81 ppm, which 
correspond to the aromatic protons of fluorene and phenyl units. Singlet peak at 3.37 ppm 
also appears. The comparison of the integrated areas between the peaks from 7.51 to 5.81 
ppm to that at 3.37 ppm confirms that four side chains have been successfully introduced to 
the monomer unit. The chemical structures of both P1 and P2 were studied by 
1
H NMR 
spectra. For P1, the ratio of integrated areas of peaks in the aromatic region from 7.80 to 7.12 
ppm (the protons of aryl and conjugated vinyl groups) to that of the singlet peak at 3.30 ppm 
(the protons of the methyl groups) is around 2.3, which is consistent with the chemical 





from 7.81 to 5.71 ppm to that of the singlet peak at 3.30 ppm is around 1.7, indicating the 
right chemical structure of P2. Direct evidence for the presence of end capper for both 
polymers is not found in the 
1
H NMR spectra. The number average molecular weight (Mn) 
and polydispersities of P1 and P2 are 39000 and 1.56, 50000 and 1.60, respectively. The 
degree of polymerization (DP) is therefore estimated to be 25 for P1 and 20 for P2 based on 
Mn and mass of repeat unit. P1 has poor water-solubility, while P2 is readily soluble in water. 
In addition, both polymers are soluble in a wide range of organic solvents such as dioxane, 
THF, acetone, dichloromethane and methanol.  
5.3.2 Optical properties 
The UV-Vis absorption and photoluminescence (PL) spectra of P1 and P2 in water are shown 
in Figure 5.1. The polymer concentration based on repeat unit is 2 µM. P1 has two absorption 
peaks centered at 438 and 467 nm and the emission peaks are at 485 and 520 nm, respectively. 
P2 has the absorption maximum at 434 nm with a shoulder around 462 nm and the emission 
peaks are at 483 nm and 517 nm, respectively. The quantum yields of P1 and P2 in water are 
0.24 and 0.45, respectively, measured using quinine sulfate (ΦF = 0.54, in 0.1 M H2SO4) as 
standard. The quantum yield of P2 in water is comparable to that in organic solvents such as 
THF (0.57) and is higher than the quantum yield of the reported cationic PFVP bearing 
ammonium groups in water (0.31).
178
 Laser light scattering (LLS) of both P1 and P2 water 
solutions were also studied. The effective diameters of P1 and P2 were not measurable at 
[RU] = 2 μM, therefore samples of higher concentrations [RU] = 0.1 mM were used. The 
effective diameters for P1 and P2 in water were measured to be 53 nm and 23 nm, 
respectively. As compared with P2, P1 with lower OEG density has stronger backbone 
aggregations, which may promote the quenching of excitons and lead to a low quantum yield. 





compared, and the results show that end functionalization does not affect the optical 
properties of P1 and P2.  












































Figure 5.1. UV-Vis absorption and PL spectra of P1 and P2 in water. [RU] = 2 µM, 
excitation wavelengths for P1 and P2 are 438 and 434 nm, respectively. 
5.3.3 Effect of surfactants on polymer optical properties  
While the interactions between water-soluble CPEs and surfactants are well-established,
179-183
 
there is few literature report regarding the interactions between neutral CPs and 
surfactants.
119
 The optical properties of P1 and P2 in the presence of sodium dodecyl sulfate 
(SDS) and dodecyltrimethylammonium bromide (DoTAB) were therefore studied. SDS and 
DoTAB differ only in head groups. Their chemical structures and critical micelle 






















































































Figure 5.2 (A) P1 and P2 absorption or emission maximum as a function of SDS 
concentration. (B) P1 and P2 emission intensity as a function of SDS or DoTAB 
concentration.  [RU] = 2 µM, excitation wavelengths for P1 and P2 are 438 and 434 nm, 
respectively. 
As shown in Figure 5.2A, with increasing concentration of SDS, the absorption and emission 
maxima of both P1 and P2 blue shift, and the maximum blue shifts observed are around 
[SDS] = 8.2 mM. Meanwhile, both P1 and P2 show significant fluorescence enhancement at 
0 to 8.2 mM range and then reach a plateau (Figure 5.2B). These results are consistent with 
the general conclusion that ionic surfactant binds with neutral polymer in the form of 
micelle-like small aggregates, and the bound amount increases until saturation occurs or 







changes of P1 and P2 are not very obvious in the presence of DoTAB. DoTAB can only 
induce a slight blue shift of the polymer absorption and emission maxima (not shown), and 
the extent of fluorescence enhancement is less than that in the presence of same amount of 
SDS for both polymers (Figure 5,2B). The clear difference of polymer spectra in responding 
to different surfactants is consistent with the general conclusion that at room temperature, 
neutral polymer interacts strongly with anionic surfactants such as SDS, but shows rather 
weak or even no interactions with cationic surfactants.
187,188
 It is explained by the fact that 
cationic surfactant DoTAB has a larger head group than that of SDS, which prevents the 
effective penetration of neutral polymers into its micelles.
177, 178
 
5.3.4 Effect of ionic strength and nonspecific interaction on polymer fluorescence 
The optical properties of both polymers under different ionic strength were also studied and 
Figure 5.3A shows the polymer emission intensities under different NaCl concentrations. 
Both P1 and P2 show almost no fluorescence or absorption change under high salt 
concentration up to 1M. This is significantly different from that of CPEs. At high salt 
concentrations, the behavior of CPE solution approaches that of uncharged polymer 
solution.
115
 Driven by the interactions between hydrophobic and rigid backbones, aggregation 




The aqueous media for analyte detection may be complex and contain a variety of 
biomolecules. Nonspecific interactions may exist and disturb the optical properties of the 
polymers.
33,34,39,40
 The environmental stability of P1 and P2 fluorescence is evaluated by 
monitoring their fluorescence in the presence of three model proteins: BSA, lysozyme and 
pepsin. The isoelectric point (pI) of BSA is 4.7, and BSA is reported to interact with a 





interactions at physiological pH (~7.4), resulting in a progressive fluorescence intensity 
increase as well as a gradual blue-shift of emission maximum.
189
 As shown in Figure 5.3B, 
different from the cationic PFBT, both P1 and P2 show almost no fluorescence change in the 
presence of same amount of BSA, suggesting no obvious variation of polymer backbone 
conformation occurs. Lysozyme (pI = 9.5) and pepsin (pI = 2.2) are two highly charged 
proteins, and are reported to interact with the oppositely charged PPEs through electrostatic 
interactions, leading to the self-aggregation and fluorescence quenching of PPEs.
190
 As 
shown in Figure 5.3B, both P1 and P2 show almost no fluorescence change in the presence of 
these two proteins. The different responding behavior of P1 and P2 from that of CPEs 
indicates that introduction of nonionic OEG layers can effectively limit the nonspecific 
























































Figure 5.3 (A) P1 and P2 emission intensities under different NaCl concentrations. (B) PL 
spectra of P1 and P2 in the presence of [BSA] ranging from 0 to 0.25 µM at an interval of 
0.05 µM, [lysozyme] ranging from 0 to 0.60 µL at an interval of 0.12 µM, and [pepsin] 
ranging from 0 to 0.10 µM at an interval of 0.02 µM in 25 mM PBS buffer, pH = 7.4. [RU] = 
2 µM, excitation wavelengths for P1 and P2 are 438 and 434 nm, respectively. 
5.3.5 Biotinylated polymer streptavidin binding on surface 
Both polymers were end functionalized with amine groups (P1-NH2, P2-NH2) to facilitate 
further attachment of different probes through conventional NHS/NH2 reaction. In this study, 
biotin functionalized polymers P1-B and P2-B were prepared for the binding with target 





We examined the surface binding ability of biotin terminated polymers to the streptavidin 
agarose resin.
191
 Four portions of streptavidin agarose resins were incubated with P1-B, 
P1-NH2 and P2-B, P2-NH2 solutions in 1 × PBS buffer using 1% Tween-20 to rule out 
possible nonspecific interactions. After removal of unbound polymer solutions, the resins 
were excited under a hand-held UV lamp. As shown in Figure 5.4, resins treated with P1-B 
and P2-B are green fluorescent, while no fluorescence is observed from resins treated with 
P1-NH2 and P2-NH2. These results indicate the interactions between P1-B, P2-B and 
streptavidin are specific. The volumes of unbound P1-B and P2-B solutions were measured 
and concentrations were determined by UV-Vis measurement. The concentrations of P1-B 
and P2-B bound to the resins are calculated to be 4.8 µmol·mL
-1
 and 4.7 µmol·mL
-1
, 
respectively, based on RU. Assuming the DPs of P1-B and P2-B are 25 and 20, respectively, 





based on polymer chain. Assuming polymers bound to the resins have one or 
two biotin terminals, and assuming these polymers interact with resins only through specific 
biotin-streptavidin interactions, the concentrations of biotin binding sites occupied by P1-B 
and P2-B are estimated to be in the range of 0.19~0.38 µmol·mL
-1
 and 0.24~0.47 µmol·mL
-1
, 
respectively. Although the exact concentrations of binding sites occupied by the polymers are 
unknown, we can still make the conclusion that the binding abilities of these biotinylated 
polymers are reasonable, because the concentrations of binding sites calculated are 
comparable to those of other biotinylated molecules such as free biotin (~0.41 µmol·mL
-1
), 
biotin 4-nitrophenyl ester (~0.27 µmol·mL
-1
) and biotinylated BSA (0.17 µmol·mL
-1
) for the 








Figure 5.4 Photographs of resins treated with P1-B, P1-NH2, P2-B and P2-NH2 under UV 
radiation at 365 nm. 
5.3.6 Biotinylated polymer streptavidin binding in solution 
FRET is a physical process whereby an excited state donor transfers energy to an acceptor 
through long range dipole-dipole coupling.
193
 The efficiency of FRET is inversely 
proportional to the sixth power of the distance between donor and acceptor centers, making 
FRET highly sensitive to distance variations.
193
 FRET has been widely used for the detection 
of molecular interactions in biological systems. We studied the binding of biotin terminated 
polymers to streptavidin in solution by conducting energy transfer experiments. The dye Cy5 
was chosen as the energy acceptor. It was expected that the binding between biotin and Cy5 
labeled streptavidin (Cy5-SA) could bring polymers and Cy5 into close proximity to meet the 
distance requirement for FRET. 
Cy5-SA was incubated with biotinylated polymers (P1-B, P2-B) and amine terminated 
polymers (P1-NH2, P2-NH2) in 1 × PBS buffer (25 µL, pH = 7.4) for 20 min, and the 
solutions were further diluted by 1 × PBS to 1 mL for PL measurements. As shown in Figure 
5.5A, the Cy5-SA emission intensity at 679 nm gradually increases with increasing 
concentration of P1-B. This indicates that binding between P1-B and Cy5-SA occurs and the 
distance between the two is close enough for FRET. Saturation occurs at P1-B [RU] = 2.0 
µM, and further increase of P1-B concentration does not lead to any Cy5-SA emission 
intensity change. The Cy5-SA emission is 7-fold of that upon direct excitation of Cy5-SA in 





the absence of P1-B, which indicates the light-harvesting property of P1. For P1-NH2 
however, no obvious spectrum change is observed after incubation with Cy5-SA, indicating 
that the interaction between P1-B and streptavidin arises purely due to the biotin terminals. 
As shown in Figure 5.5B, binding between P2-B and Cy5-SA also occurs. Cy5-SA emission 
intensity saturates at [RU] = 0.5 µM, which is 2.5-fo ld of that upon direct excitation of 
Cy5-SA in the absence of P2-B. Similar to P1-NH2, P2-NH2 does not show obvious 
spectrum change after incubation with Cy5-SA.  
The concentration of P1-B is higher than that of P2-B at saturation points in the presence of 
same amount of streptavidin. This could probably be explained by the fact that P1-B is less 
water-soluble than P2-B, and the biotin ends of P1-B are more likely to be trapped within the 
P1-B aggregates, and less portion of biotin ends of P1-B are readily accessible for 
streptavidin binding. P1-B functions as a more efficient energy donor compared to P2-B. 
Considering the fact that both polymers have same backbone chemical structures and the 
shapes of the emission spectra are similar, it is probably the differences of their morphologies 
in solutions that lead to the different  center-to-center distances (   ) and/or orientation 
factors ( ) and subsequently different FRET. 
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Figure 5.5 (A) PL spectra of P1-B and P1-NH2 solutions after incubation with Cy5-SA in 1× 
PBS, pH = 7.4. After dilution with 1 × PBS, pH = 7.4, P1-B concentrations are 0, 0.50, 1.0, 
1.5 and 2.0 µM, P1-NH2 concentration is 2.0 µM, and [Cy5-SA] = 3.3 × 10
-8
 M. (B) PL 
spectra of P2-B and P2-NH2 solutions after incubation with Cy5-SA in 1× PBS, pH = 7.4. 
After dilution with 1 × PBS, pH = 7.4, P2-B concentration is 0 and 0.50 µM, P1-NH2 
concentration is 0.50 µM, and [Cy5-SA] = 3.3 × 10
-8
 M. Excitation wavelengths for P1 type 
and P2 type are 438 and 434 nm, respectively. 
 
5.4 Conclusion 
We have successfully synthesized two neutral end functionalized conjugated polymers. P2 
with a thick OEG shell has excellent water solubility and high quantum yield (0.45). In 
addition, the introduction of OEG side chains also renders both polymers with good optical 
stability in high slat solutions (up to 1 M) and minimal nonspecific interactions with 
biomolecules. Biotinylated polymers show reasonable binding abilities in solid surfaces, and 
can function as energy donors to detect the biotin-streptavidin recognition event in 
homogenous solutions. These desirable optical properties (high quantum yield, optically 
stable) as well as specific surface and solution recognition capabilities make the materials 
attractive in biological applications. 
In terms of material design, OEG chains were introduced to the fluorene unit to achieve the 
water solubility of the final polymers. The monomer units will enable the further 





various polymerization protocols such as Suzuki, Heck or Yamamoto coupling reactions. 
Besides the ligand biotin, other receptors such as antigens, nucleic acids, or enzyme 
substrates can be conjugated to the CP chains for the detection of antibodies, nucleic acid 








CONCLUSION AND RECOMMENDATION 
 
One objective of this research study was to widen the applications of CPs and to develop 
novel CP based heparin sensors.  
Firstly, a cationic conjugated polymer containing 20 mol-% BT content was synthesized 
through a post-polymerization method. With a good water solubility (20 mg·mL
-1
), this 
polymer showed a low inherent BT emission in aqueous solution. Formation of 
interpolyelectrolyte complexes between the oppositely charged polymer and heparin 
facilitated energy transfer from fluorene segments to the BT unit within the polymer, leading 
to the intensity increase for the orange emission and the intensity decrease for the blue 
emission. By correlating the changes in BT emission with the heparin concentration, we 
obtained a practical calibration curve ranging from 0.02 to 8.0 U/mL. The significant 
advantage of this heparin macromolecular probe was that the calibration curve could cover 
the whole range of the therapeutic dosing level of heparin.  
Secondly, a water-soluble pyrene-based conjugated oligoelectrolyte (TFP) was synthesized 
and was integrated with GO for heparin detection. Efficient fluorescence quenching occurred 
between TFP and GO due to the strong electrostatic and π-π interactions, leading to nearly 
dark emission in the absence of analytes. Addition of heparin into TFP solution significantly 
minimized the fluorescence quenching of GO towards TFP, which was less effective for the 
heparin analogues such as HA and ChS. Light-up visual discrimination of heparin from its 
analogues was realized as the solution emitted strong yellow fluorescence only in the 
presence of heparin. A linear response of the TFP/GO integrated assay enabled heparin 
quantification in the range of 0 to 1.76 U/mL, which was practical for heparin monitoring 





We further demonstrated a strategy for the real time naked-eye detection and quantification 
of heparin in the biological medium by monitoring the absorbance change of a water-soluble 
cationic polythiophene. Electrostatic interactions between polymer and heparin led to 
polymer conformation and color change from yellow to orange in solution. Under optimized 
conditions, addition of heparin derivative HA or ChS to the same polymer solution led to less 
change in polymer conformation and solution color due to their lower charge density as 
compared to that of heparin. Increasing the detection temperature or adding some organic 
solvent to the aqueous media reduced the polymer-polymer interchain π stacking, and the 
polymer color change can be used to clearly differentiate heparin from its analogue in 
homogeneous solutions. By correlating the change in polymer absorbance to the heparin 
concentration, we obtained a linear calibration curve in the range of 0 to 6.7 U/mL and 0 to 
2.2 U/mL in pure water and in FBS, respectively.  
Although we successfully demonstrated three CP based sensors for heparin detection and 
quantification, this study still have some limitations.  
(i) The crude heparin or even USP heparin usually contains a mixture of polysaccharides 
introduced from the raw materials or other possible semi-synthesized or synthesized 
economically motivated additives. Multiple orthogonal analytical techniques are required to 
identify the contaminants. In fact, few of the current colorimetric/fluorometric assays can 
clearly differentiate heparin from other contaminants, and more importantly, few of the 
current assays can differentiate heparin and contaminants from their mixtures or real samples. 
In this study, although we successfully demonstrate that these CPE-based assays show 
different responses towards different analytes studied, similar to previous studies, we do no 
show that these assays can differentiate between mixtures of negatively charged polymers. In 





(ii) Among the possible contaminants, the one of particular interest is oversulfated 
chondroitin sulfate A. OSCS is synthesized by chemical sulfonation of chondroitin sulfate A, 
an inexpensive substance for the treatment of osteoarthritis. Administration of heparin 
contaminated by OSCS led to nearly 100 deaths in USA.
194
 Therefore, the companies are 
required to provide the information about the amount of OCSC in heparin. In this study, we 
only chose HA and ChS, two polysaccharides with charge densities lower than that of heparin 
as analytes. We do not study the CPE responses towards OCSC, a compound with negative 
charge density even higher than that of heparin. 
(iii) Blood samples containing heparin are detected clinically, however, only serum is used 
here as the biological media. Protamine is used to neutralize excess amount of heparin, and 
appropriate amount of protamine should be administrated because protamine its own is a 
toxic drug and is related to adverse responses.
195
 Fluorimetric and colorimetric responses 
after titration with protamine can also be studied. 
(iv) PFBT type polymer aggregates under high salt concentration and under high polymer 
concentration, which ultimately affect the performance of the assay. In addition, the 
interactions between CPEs and heparin are mainly nonspecific electrostatic interactions, 
interfering molecules in the sample may lower the sensitivity and selectivity of the assay. 
Based on the literature review of recent assays, results and discussion present and the 
conclusion drawn from this research work, we propose some possible modification methods 
to overcome above limitations.  
(i) In Chapter 4, we demonstrate that polythiophene show distinctive responses towards three 
analytes. Polysaccharides and additives exist in the heparin sample differ in chain length, 
backbone composition, charge density, charge arrangement, conformation and so on, and 





further reflected by the polythiophene optical properties. Polythiophene derivatives differ in 
ionic groups (cationic, anionic or zwitterionic), side chain (chain length, linear or branched 
chains, OEG chain), and backbone length (oligothiophene, polythiophene) can be developed 
and are expected to interact with analytes in different patterns. An array of these 
polythiophene derivatives can be formed for the detection of heparin samples in a microplate 
format. The data can be processed using techniques such as linear discriminant analysis 
(LDA) to classify and quantify the possible contaminants.
196
 It should be noted that this 
method cannot give chemical or structural information about the contaminant as NMR does, 
therefore, it may possibly fail if new types of economically motivated additives are 
introduced to heparin sample.  
(ii) Due to the high charge density nature of OCSC, discrimination between OCSC and 
heparin is expected to be difficult using currently developed CP based sensors. Heparinase, 
an enzyme which cleaves heparin into small fragments can be used to treat the sample prior 
the detection process. Short fragments produced are expected to trigger a sensor response 
different from that in the presence of heparin.  
(iii) Solubility of PFBT was obtained because oligo(ethylene glycol) side chain and ammonium 
groups show better affinity to water, and ammonium groups show electron repulsion force towards 
each other. Buffer ions screen the repulsion forces and lower the water-solubility of PFBT and lead to 
the aggregation of the polymer. Solubility of PFBT needs to be further improved by using longer 
oligo(ethylene glycol) chains or attaching side chains with higher charge densities. Nevertheless, 
close contact of segments or aggregation of PFBT after addition of heparin need to be guaranteed. 
Due to the intrinsic hydrophobic and charge nature of CPEs and interfering molecules, 
nonspecific interactions are unavoidable. Therefore, nonionic conjugated polymers based 
assays are preferred. Recently, our group
197
 developed a biocomponent FRET probe for the 





(donor) and a mannose-substituted neutral conjugated oligomer (acceptor). Due to the 
nonionic nature of side chains and short hydrophobic backbone, the oligomer has only weak 
interactions with nonspecific molecules. FRET between polyfluorene and oligomer 
selectively occurs in the presence of Con A as the mannose-Con A specific interaction brings 
the two into close proximity. This biocomponent probe can also be applied for the selective 
detection of heparin by replacing mannose groups with boronic acid groups,
106-108
 which 
specifically interact with heparin even in serum. In addition, the fluorene unit carrying 
charged sides in the cationic polyfluorene can be replaced by the water-soluble nonionic 
fluorene unit to further reduce possible nonspecific interactions. 
Despite various limitations of aPTT method, it still continuous to be the widely used assay for 
heparin level in clinical practice due to its readily available and familiarities. More 
importantly, this method relies on the detection of heparin functional activities. The actual 
concentration of heparin determined by the chemical method may not be clinically relevant, 
because the percent of heparin active domains or pentasaccharide domains that bind with 
antithrombin may vary between different batches. Chemical method can therefore function as 
a complementary method to aPTT.  
Another objective of this research study was to develop new functionalized water-soluble 
nonionic conjugated polymers.  
Two fluorene monomers carrying two or four OEG side chains were synthesized. The 
nonionic PFVPs end capped with protected amine groups were then obtained through Heck 
coupling between monomers and 1,4-divinylbenzene followed by end capping step. Polymer 
with low OEG density (P1) was not readily soluble in water and had a quantum yield of 0.24, 
while polymer with higher OEG density (P2) showed excellent water solubility and had a 





equal to that of P2 with the assistance of anionic surfactant SDS. Both polymers were 
optically stable under high salt concentrations and had minimal nonspecific interactions with 
biomolecules. Biotin was incorporated into polymer chain ends through conventional 
NHS/NH2 reaction. We showed that both biotinylated polymers can interact with streptavidin 
on solid surface and in solution in a highly specific manner.  
Although we successfully developed two functionalized water-soluble nonionic polymers and 
demonstrated their biorecognition abilities, this work still has some limitations. The 
following listed the limitations and some recommendations. 
(i) Purification of biotinylated polymers are needed to collect those polymers with one or two 
ends functionalized with biotin molecules. Collection of biotinylated molecules from the 
streptavidin resins are commonly realized using guanidine/HCl, pH = 1.5 or through boiling 
the beads in SDS-PAGE buffer.
198
 These two methods are not suitable for CPs because acid 
aqueous solutions may damage CPs
199
 and SDS can bind with CPs through hydrophobic 
interactions. Therefore, monomeric avidin resins with much gentle purification conditions 
(2mM biotin in PBS) are recommended. 
(ii) Although we showed that the introduction of OEG side chains can effectively minimize 
the nonspecific interactions between polymers and interfering proteins, we do not further 
study the selectivity of biotinylated polymers. Besides incubating biotinylated polymers with 
Cy5-SA alone, biotinylated polymers should also be incubated with a mixture of Cy5 labeled 
proteins including Cy5-SA and without Cy5-SA, and the results should be compared to 
demonstrate the selectivity of the functional polymers. 
(iii) Two principle fluorene units were developed in this study, and we only used them to 
develop PFVP type polymers. These fluorene units can be incorporated into other PF type 





polymerization methods. In addition, besides biotin, various receptors can be coupled to the 
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